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CHAPTER I 
Introduction 
 
 
Some of the earliest optical instruments -- simple tubes with a single lens in one 
end, appropriately known as “flea tubes” -- were applied to viewing magnified images of 
biological specimens such as insects and fleas. As early as the late 17th century, Anton 
van Leeuwenhoek, the Dutch scientist widely considered the father of microscopy, was 
applying his carefully constructed microscope to examine the human body, and 
discovering previously invisible details of micro-anatomy such as erythrocytes in blood1. 
Over the last three centuries, optical microscopy has played a critical role in the 
development of our current understanding of cellular physiology and molecular biology. 
Currently, the modern field of pathology relies almost exclusively on microscopic 
evaluation of stained tissue samples as the gold standard for crucial medical diagnoses of 
diseases such as cancer. However, our current understanding of the nature of cancer and 
optimal treatment strategies has made it clear that screening and early detection, accurate 
diagnosis, and appropriate staging are all critical in directing treatment to obtain the best 
outcomes. In the case of epithelial cancers, particularly those of the skin, screening and 
early detection can be particularly challenging. Physicians are forced to examine a large 
area containing a number of non-malignant lesions and isolate those that are cancerous 
for biopsy and pathology. This paradigm can be subjective, painful for the patient, time-
consuming, and costly. Fortunately, techniques for optical analysis have developed 
significantly since the days of van Leeuwenhoek. An improved understanding of the 
nature of light and it’s interaction with tissues, the development of methods such as 
spectroscopy and interferometry, and technological developments such as fiber optics and 
the charge-coupled-device (CCD), have facilitated the development of optical techniques 
far beyond simple microscopic evaluation. Identification of the sub-optimal nature of 
biopsy and histology and an appreciation of enhanced capabilities of novel optical 
methods has spurred the challenge of performing non-invasive direction of treatment with 
modern optical methods – an approach broadly dubbed “optical biopsy”. In the last 20 
years, the enthusiastic application of a number of optical imaging and spectroscopy 
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techniques has identified the strong potential – and practical limitations – of these 
approaches to performing true optical biopsy. To date, no single method has 
demonstrated the ability to perform screening, diagnosis, and staging of cancers 
sufficiently well that cancer therapies can be directed without the need for physical 
biopsy. The current task we are now faced with is how to best apply these techniques to 
the challenge of performing true optical biopsy. 
Motivation 
Prior to the initiation of this dissertation, our group here at Vanderbilt had 
established itself as one of the leading groups in the field of in vivo Raman spectroscopy 
(RS), a technique that is capable of characterizing the specific biochemical composition 
of tissues based on the in-elastic scattering of light2.  The ability of fiber-optic probe 
based RS to detect cervical dysplasia in the demanding clinical environment had been 
demonstrated with excellent results3. In the context of skin cancer diagnosis, in vitro and 
in vivo studies using confocal RS had demonstrated the potential for multi-class diagnosis 
of skin lesions with excellent overall classification accuracies4, 5. This body of work 
identified two issues with RS in the context of performing optical biopsy of skin cancers.  
The most direct issue is the question of whether a confocal collection geometry is 
necessary for accurate classification of skin cancers with RS.  The motivation behind 
using a confocal approach was to isolate the spectral features of cancerous cells from 
those originating in the surrounding epidermis and dermis, thus improving the diagnostic 
accuracy of the technique. However, a compelling finding from the in vitro and in vivo 
studies was that regardless of whether the instrument specifically focused on cancerous 
cells or the non-involved dermis, confocal RS was able to classify cancerous tissues with 
overall accuracy > 90%. Results from the in vivo study indicated that confocal RS could 
identify the presence of cancers when the collection volume was as far as 900 µm away 
from the tumor margins. These findings are supported by observations from other groups, 
which have reported that peri-tumoral changes in the collagen and dermis surrounding a 
skin cancers can be detected by Raman spectroscopy6, 7. The natural question that arises 
is, “Does accurate spectral classification of skin cancers with RS require a confocal 
collection geometry?” The relevance of this question is related to the primary clinical 
limitation of confocal RS – the collection geometry necessitates integration times on the 
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order of 30 sec in comparison to fiber optic probe acquisition times of only 3 seconds. 
Understanding whether or not a confocal collection geometry is necessary would thus 
significantly impact the development of future Raman studies and instrumentation.  
The primary limitation of both fiber optic probe and confocal RS, however, is the 
fact that the inherently weak nature of in-elastic scattering limits in vivo RS to a few 
point-based measurements in a clinically relevant time-frame and precludes the 
generation of Raman maps that could identify the spatial aspects of pathological tissues. 
This can be problematic for two reasons; 1.) Because lesions are identified based on their 
visual appearance alone, site selection for RS can be just as susceptible to sampling error 
as biopsy, and 2.) Understanding the morphology and spatial extent of cancers is critical 
to pursuing the appropriate course of treatment. Based on these criteria, a complimentary 
optical technique to RS was sought out in order to create a dual-modal device capable of 
rapid non-invasive characterization of the morphological features of cancer.  
Optical coherence tomography (OCT) is a novel optical imaging modality capable 
of generating cross-sectional images in highly scattering tissues with micron-scale 
resolution that well fits this bill8. In contrast to other non-invasive optical imaging 
techniques such as confocal reflectance microscopy, axial resolution in OCT is defined 
by spectral bandwidth of the laser source as opposed to the numerical aperture of the 
focusing optics. This permits OCT to rapidly collect high resolution images over a large 
transverse area, which is advantageous for identifying tumor margins and gross 
morphology.  In addition, OCT had been demonstrated capable of visualizing the 
microstructural features of a wide range of skin cancers9-11.  The limitation of OCT, 
however, is that it simply detects backscattered light, and therefore has no direct ability to 
ascertain the molecular or biochemical composition of tissues, which is critical for high 
specificity detection of disease. In this context, the combination of OCT with RS can also 
provide significant benefit to the application of OCT for the diagnosis of cancers. The 
two techniques are ideally complimentary and well suited for integration into a common 
instrument designed for screening, diagnosis, and staging of cancers. 
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Specific Aims 
The goal of this dissertation is to develop the method of combined Raman 
spectroscopy – Optical Coherence Tomography (RS-OCT) and construct a clinical 
system for the in vivo measurement of questionable skin lesions. The significance of a 
combined RS-OCT instrument would lie in its ability to address each of the critical 
charges required of optical biopsy. The ability of OCT to perform high speed imaging 
would allow high sensitivity, rapid, screening of the large areas for the morphological 
features of disease. Raman spectra could then be acquired from the lesion sites, and the 
biochemical composition of the lesion could be used to perform accurate diagnosis. 
Closer examination of the lesion morphology with OCT could then provide an estimation 
of lesion margins and depth of invasion, which is critical for appropriate staging. The 
successful realization of such a device would present a significant step towards the goal 
of optical biopsy. 
Specific Aim #1  
Aim #1 of this dissertation is to perform a pilot study assessing the ability of 
fiber optic probe based RS to classify skin cancers. A pilot study was conducted in 
which spectra from 34 lesions from cancerous and non-cancerous lesions, along with 
matched spectra from similar normal skin,  were measured with fiber optic probe based 
RS. Difference (lesion – matched normal) spectra were calculated to account for the 
inherent variation in skin. Difference spectra were classified using Sparse Multinomial 
Logistic Regression (SMLR). Spectra were classified with an overall accuracy of 85%, 
with a sensitivity of 78% and a specificity of 94%. These results suggest the potential 
utility of non-confocal RS for accurate classification of skin cancers, however a more 
extensive research is necessary.  
Specific Aim #2 
Aim #2 of this dissertation is to develop a benchtop combined RS-OCT 
system utilizing separate OCT and Raman system backbones. A dual-modal device 
capable of sequential acquisition of Raman Spectroscopy (RS) and optical coherence 
tomography (OCT) along a common optical axis was constructed. The system 
performance was characterized, and capability of the device to identify structurally 
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ambiguous features within an OCT image with RS in a scattering phantom, guide 
acquisition of RS from a localized malignancy in ex vivo breast tissue, and perform in 
vivo tissue analysis of a scab. The device enhances application of both RS and OCT by 
precisely guiding RS acquisition with OCT images while also compensating for the lack 
of molecular specificity in OCT with the biochemical specificity of RS. The results 
indicate the potential capability of RS-OCT for in-vivo morphological and biochemical 
analysis of the skin.  
Specific Aim #3 
Aim #3 of this dissertation is to develop a benchtop combined RS-OCT using 
a common detection arm. Previous implementations of RS-OCT have employed 
separate system backbones for OCT and RS. Here, we present the design and application 
of a common detector combined RS-OCT instrument for evaluating the morphological 
and biochemical differences in tissue. The instrument is applied to evaluating a rat model 
for oxygen induced retinopathy. Rat pups that have undergone a variable oxygen 
treatment are compared to rats raised in room air. Images and spectra collected at an age 
of 26 days postnatal demonstrate differences in the thickness of the inner and outer 
nuclear layers, with OCT  as well differences in the Raman spectral bands attributed to 
DNA and RNA nucleotides, amino acids, and proteins. The results from this study 
demonstrate the first implementation of common detector RS-OCT, however they 
suggest that the independent detection of the RS and OCT signals is the optimal approach 
for in vivo analysis of skin lesions.  
Specific Aim #4 
 Aim #4 of this dissertation is to develop a clinical system for combined RS-
OCT for analysis of the morphological and biochemical features of skin cancer. The 
portable instrument utilizes independent RS and OCT system backbones, and is 
integrated in a common clinical probe. The potential of the probe for cancer detection of 
the morphological and biochemical features of malignant and non-malignant lesions is 
demonstrated. The results from this aim indicate the potential of RS-OCT for evaluating 
skin cancers, and warrant more extensive work. 
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Background 
Skin Microstructure, Skin Cancer, and Skin Cancer Management 
Normal Skin Microstructure 
   Normal human skin is composed of two main layers, the epidermis and the 
dermis, which lie above a layer of subcutaneous fat that separates the skin from the 
underlying fascia and muscle (figure 1).  
 
Fig.  1: Normal Human Skin Histology. The main layers of the skin can be clearly visualized, from top to 
bottom, as the epidermis (E), the dermis (D), and the subcutaneous fat (SCF)12. 
 
The topmost layer of skin is the epidermis, which varies in thickness from 50 µm in the 
eyelids to 1.5 mm in the palms and soles of the feet 13. The epidermis is a stratified 
squamous epithelium whose principal cell type is the keratinocyte. Keratinocytes are 
produced by cell division in the bottommost layer of the epidermis, known as the stratum 
basale (basal layer), and migrate upward as they undergo keratinization. The stratum 
basale is also the layer of the epidermis in which the pigment producing melanocytes 
reside. As keratinocytes differentiate, they progressively accumulate keratin (a family of 
intracellular skeletal protein filaments), flatten, lose their nuclei, and finally die and are 
reduced to strains of keratin filaments. As the cells migrate, they pass through the 
following layers of the epidermis (from bottom to top) 14: the stratum spinosum, which is 
the predominant keratinocyte layer, the stratum granulosum, which consists of flattened, 
anuclear, cells with large amounts of keratin, and the stratum corneum, which is primarily 
the remaining keratin filaments left over after the keratinocyte has died (fig. 2). 
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Fig.  2: Histology of Normal Epidermis and Dermis. Here the layers of the epidermis can be clearly seen. 
The stratum corneum (SC), the stratum granulosum (SG), the stratum spinosum (SS), the stratum basale 
(SB). Beneath the epidermis is the dermis (D). 15 
 
The dermoepidermal interface is formed by a thin basement membrane that consists of 
the lamina lucida and the lamina densa. The lamina lucida is in contact with the 
epidermis, while the lamina densa is in contact with the dermis. The dermis is a dense 
layer primarily composed of collagen along with lesser amounts of elastin. These 
structures give the dermis great elasticity and strength. The dermis also contains sensory 
cells and vascular networks. 
Skin Cancer   
  Skin cancer is the most commonly occurring of all cancers, accounting for more 
than a million incidences (about half of the total number of cancer incidences) in the 
United States annually 16. Fortunately, the two most commonly occurring skin cancers 
(basal cell carcinoma and squamous cell carcinoma), have survival rates of better than 
98%, with mortalities coming mostly from immuno-compromised patients or elderly 
patients with advanced disease. The American Cancer Society estimates 800,000 to 
900,000 new cases of basal cell carcinoma in 2006 along with 200,000 to 300,000 new 
cases of squamous cell carcinoma 16. The most dangerous of skin cancers is malignant 
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melanoma, which accounts for only 4% (approx. 62,000 cases) of all skin cancer 
occurances but nearly 80% of skin cancer related deaths 17.  
 Although basal cell carcinomas (BCC’s) are the most commonly occurring types of 
skin cancers, they are also one of the least dangerous due to their slow growth rate and 
the extreme rarity with which metastases occur. BCC’s arise from transformed epidermal 
stem cells in the basal layer, such that upon pathological analysis, the tumor cells have a 
characteristically columnar appearance (fig. 3).  
 
Fig.  3: Histology of basal cell carcinoma. In the low magnification image (A) you can clearly see the 
nests of cancerous cells. High magnification (B) shows peripheral pallisading (arrow) 15. 
 
BCC’s tend to form nests of tumor cells whose peripheral borders appear as an orderly 
line of basal cells (termed “peripheral pallisading”) and whose centers possess similar 
cell types with low amounts of cytoplasm. Clinically, BCC’s present in 4 variants: 
superficial, nodular, pigmented, and sclerosing (fig. B.4) 18.  Superficial BCC’s occur 
most commonly on the trunk and extremeties and present as red to pink scaling plaques, 
with occasional shallow erosions. Nodular BCC’s occur on the face and ears, and begin 
as small, firm, dome-shaped translucent papules. Pigmented BCC’s are often confused 
with melanomas. Sclerosing BCC’s occur most often on the face and appear as an 
indurated, white plaque with a atrophic surface. Clinical recognition of BCC’s can be 
difficult because of their resemblance to other clinical entries such as sebaceous 
hyperplasia and molluscum contagiosum (similar to nodular BCC) or eczema and 
psoriasis (similar to superficial BCC). Risk factors for the development of BCC include 
fair skin and Celtic ancestry, cumulative over-exposure to UV light, ionizing radiation, or 
arsenic, and patients who are on immunosuppressive medications 18.  
9 
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Fig.  4 Common clinical presentations of basal cell carcinoma: BCC presenting as a pink patch with 
pearly borders (A), Nodular BCC on the nose (B), Superficial Pigmented BCC behind the ear. Note the 
similarity to melanoma (C), and recurrent sclerosing BCC (D) 18. 
. 
 Squamous cell carcinoma (SCC) is the second most commonly occurring type of skin 
cancer, however it is more aggressive in comparison to BCC. The metastatic rate of SCC 
is 2% to 6% in sun-damaged skin, 10% in SCC’s involving the lip, and 30% in SCC’s 
involving scars 18. SCC’s originate from transformed cells in the stratum spinosum, and 
have the potential to develop downwards and invade into underlying structures. SCC’s 
appear pathologically different than BCC’s. The tumor nests are bordered by polygonal 
cells with larger degrees of cytoplasm than BCC’s. SCC tumor cells also differentiate 
towards the center of the nests such that the nest centers often have sections of 
keratinized epidermal cells which appear as “keratinized pearls” (fig. 5) 19.  
 
Fig.  5: Histology of squamous cell carcinoma. A low magnification view shows the keratinized tumor 
cell nests(A), which are more clear in the high magnification view (B). Arrow points to keratinized pearl 15. 
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The degree to which a SCC has differentiated is the basis for their grading (called 
Broder’s classification), with poorly differentiated SCC’s presenting a higher risk for 
invasion and metastases. Clinically, SCC’s present with the most prevalence on the face, 
ears, scalp, and dorsum of the hands. SCC’s normally begin as small erythematous, scaly, 
crusted patches (fig. 6). 
C
B
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Fig.  6: Common clinical presentations of squamous cell carcinoma. In addition to the head, as shown 
by the SCC above the eye (A), SCC’s also present on places such as the hand (B) and leg (C) 18. 
 
Clinical differentiation of SCC’s from other skin lesions also normally requires histo-
pathological analysis as they can often be confused with non-cancerous lesions. Risk 
factors for SCC include cumulative exposure to both UV-A and UV-B light, Celtic 
ancestry, poor tanning ability, severe sunburns during childhood, exposure to ionizing 
radiation, thermal burns and scars, and the use of artificial tanning booths 18.  
 Malignant melanomas are the rarest, but most deadly form of the common skin 
cancer. Melanomas arise from transformed melanocytes in the basal layer of the 
epidermis. The cancerous cells then spread upwards into the epidermis as well as 
downwards into the dermis and underlying tissues (fig. 7).  
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Fig.  7: Tumor Progression to Melanoma. Normal melanocytes in the basal layer (A) undergo 
transformation (B), and progress to form tumor nests (C). This progression results in the emergence of 
clone malignant cells which proliferate in close proximity to the epidermal layer (D) in the radial growth 
phase. Eventually, these cells gain the ability to invade the tissue (E) in the vertical growth phase 15. 
 
Malignant melanomas are graded on Clark’s scale, which examines the anatomic level of 
tumor cell invasion ranging from level I (tumor cells all above the basement membrane) 
to level V (tumor cells have broken the basement membrane, invaded the through the full 
depth of the dermis and into the subcutaneous layers) 18. Clinically, melanomas appear as 
dark pigmented lesions with 4 subtypes: Lentigo maligna, superficial spreading 
melanoma, acral lentiginous melanoma, and nodular melanoma (fig. 8).  
B
A
 
Fig.  8: Clinical presentations of melanoma. Two clinical presentations of malignant melanoma include 
nodular (A) and acral lentiginous (B) melanoma 18. 
 
 The first 3 initially spread horizontally before vertical invasion, and therefore have an 
excellent prognosis if diagnosed early enough. Nodular melanoma, however, almost 
immediately begins a vertical growth phase and is therefore associated with a much 
worse prognosis. Risk factors for melanoma include intense, intermittent, exposure to UV 
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radiation at an early age, Celtic ancestry, and individuals with genetic predisposition. 
Cumulative UV exposure and melanoma risk are not linearly correlated, thus partially 
explaining the increased occurrence of melanomas on the back of men and the legs of 
women when compared to BCC or SCC 18. 
Skin Cancer Management 
  Currently, the gold standard for skin cancer diagnosis is histopathological 
evaluation of tissue biopsies. Depending on the nature of the skin lesion, different types 
of biopsies are performed. For raised skin lesions not believed to be melanocytic, a shave 
biopsy is performed. For flat lesions and lesions where it is imperative that a full-
thickness specimen is taken, a punch biopsy may be advantageous. Almost all lesions 
suspected to be melanocytic that are small enough, however, are removed via excisional 
biopsy. Excisional biopsy removes the entire lesion including a margin of normal skin at 
a depth that extends into the subcutaneous tissue. This is to ensure proper analysis of the 
depth profile of the lesion as well as a precautionary method. In suspicious lesions that 
are potentially non-melanomas, incisional biopsies can be taken where only a portion of 
the lesion is removed for histological analysis. All of these techniques for biopsy are 
invasive, time-consuming, and painful for the patient. Additionally, in patients who 
present with multiple similarly appearing lesions, the selection of the site for biopsy is 
subjective and could result in misdiagnosis 18.  
 In the event that pathological evaluation determines the lesion to be cancerous, 
the treatment options again depend on the type of cancer and its stage. The most common 
for almost all small lesions is simple surgical excision. For BCC’s and SCC’s that remain 
in the epidermis and are in not in cosmetically sensitive areas, electrodesiccation and 
curettage is a cost-effective, quick, and safe method. Cryosurgery with liquid nitrogen is 
another viable alternative for superficial cancers in which the tumor is essentially frozen 
off. Alternatively, topical treatments such as 5-fluorouracil or Imiquimod can be effective 
tools for in situ disease, however these treatments still require close monitoring20.  
Mohs micrographic surgery is the technique with the highest cure rate, and is the 
treatment of choice for removal of sclerosing and recurrent BCC’s in addition to large 
BCC’s and SCC’s. In this surgery, the tumor is excised in thin layers which are mapped 
to their relative location on the patient and pathologically evaluated. If tumor cells appear 
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in a section, then additional tissue sections are removed until the entire tumor and its 
margins are removed. Mohs surgery is a significant improvement over the previously 
mentioned techniques in that it ensures complete removal of the tumor and thus 
minimizes recurrence, along with minimizing the amount of extraneous tissue removed. 
Because of the chance for recurrence, patients are monitored after surgery, and in the case 
of invasive disease, additional treatment options including radiation and chemotherapy 
can be administered 18.  
 Although the current gold standard for evaluation of potentially cancerous skin 
lesions is effective, it is far from perfect. Biopsy is an invasive and painful procedure that 
is often unnecessary when the lesions are benign. The procedure is also time-consuming 
and expensive. In addition, a number of elderly patients at the highest risk for skin 
cancers often present with a large number of suspicious skin lesions, making selection of 
biopsy locations subjective and laden with the potential for missed diagnoses. Thus, there 
remains a need for a non-invasive technique that can reliably analyze suspicious lesions 
in situ in real-time and serve as a method to initially guide biopsy and eventually 
potentially serve as a replacement for histo-pathological analysis. Such a method would 
enable a significant cost-savings by reducing patient visits and facilitating the diagnostic 
and therapeutic procedures to be performed in a single visit. Additionally, such an 
approach would allow for the thorough screening of patients with a large number of 
suspicious lesions and potentially even reduce the likelihood of undiagnosed disease. 
Two complimentary optical modalities have recently emerged as promising diagnostic 
techniques for the skin; Raman spectroscopy and optical coherence tomography. 
Raman Spectroscopy 
  Raman spectroscopy is an optical technique that probes the specific molecular 
content of a sample by collecting in-elastically scattered light. Raman spectroscopy is a 
regularly used tool in analytical chemistry to determine the presence of specific 
molecules in mixed samples, however recent studies have shown it’s utility for 
investigating cancerous human tissues. In vitro examples include the analysis of tissues 
from the breast 21-23, cervix 24, bladder and prostate 25, lung 26, and GI tract 27. Examples 
of recent in vivo applications include the cervix 28, GI tract 27, and the breast 29. 
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Raman Spectroscopy Theory  
  Raman spectroscopy is based on the in-elastic (or Raman) scattering of light. As 
photons propagate through a medium, they undergo both absorptive and scattering 
events. In absorption, the energy of the photon is completely transferred to the material, 
allowing either heat generation (internal conversion) or a re-emission phenomena, such as 
fluorescence or phosphorescence, to occur. Scattering, however, is normally an elastic 
process, in which the energy state of the incident photon and the molecule it collides with 
remain unchanged (Rayleigh/Mie scattering). In Raman scattering, the interaction 
between the photon and molecule results in an instantaneous transfer of energy between 
the incident photon and the molecule. The range of energy shifts is quantized and limited 
to the energy band-gap between the molecule’s current vibrational mode and the other 
possible vibrational modes of the molecule. In cases where the photon is red-shifted due 
to a transfer of energy to the molecule, the in-elastic scattering is referred to as Stokes 
scattering. When the photon is blue-shifted due to a transfer of energy from the molecule 
to the photon, the in-elastic scattering is referred to as anti-Stokes scattering. (fig. 9). 
Because the scattering interaction is based on the specific allowed vibrational modes of a 
molecule, every molecule has a unique Raman signature. 
 
Fig.  9: Jablonski diagram of Raman scattering. In comparison to fluorescence, which involves energy 
transfers on the order of electronic states, and elastic (Rayleigh) scattering, which involves no energy 
transfer, Raman scattering involves energy transfers on the order of the vibrational modes of a molecule.  
 
Unfortunately, Raman scattering is a very weak phenomena. For every 10 million 
elastically scattered photons, approximately 1 is Stokes scattered. Practical measurement 
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of Raman spectra thus requires extremely sensitive detection hardware, and often high 
power excitation laser sources. Even with these components, intense tissue auto-
fluorescence masks the Raman signal. After detection, post processing techniques are 
required to subtract the fluorescent background and enable accurate visualization of the 
Raman spectra. Raman spectra are plots of scattered light intensity as a function of 
frequency shift in units of wavenumber (cm-1). The region of the Raman spectra where 
most biological molecules have Raman peaks is from 500 to 2000 cm-1. In contrast to 
fluorescence spectra, Raman spectra have a number of sharp spectral features that enable 
easier identification of the contributing molecules. In the context of detecting cancerous 
tissues, a wide variety of differences are seen in the Raman spectrum. For example, 
Raman spectra of cancerous tissues exhibit an increased contribution from spectral 
features that are associated with nucleic acids, corresponding with the known increase in 
nuclei-to-cytoplasm ratios associated with malignancy 30. 
High Power Laser
Sample
Raman
Backscatter
Collection Spectrograph
CCD
 
Fig.  10: Diagram of Typical Raman Spectroscopy System. 
 
 A block diagram of a typical NIR-Raman spectroscopy system is shown in figure10. 
Raman excitation is provided by a high power mode-locked laser. The Raman scattered 
light is then collected and spectrally separated by a spectrograph before being detected by 
a high-sensitivity CCD detector and sent to computer for digitization and processing. 
Raman Spectroscopy of Skin Cancer 
  In the human skin, a number of studies have been performed to examine the 
biochemical composition of normal and pathological samples both in vitro and in vivo. 
Initial experiments using Fourier Transform (FT) Raman on in vitro skin samples 
determined Raman spectroscopy to be a promising technique for the diagnosis of 
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pathological skin lesions, including BCC, SCC, and malignant melanoma 31. An  
extensive in vitro FT-Raman study followed, which demonstrated the ability of RS to 
perform differential diagnosis of malignant melanoma, pigmented nevi, BCC, 
seborrhoeic keratosis, and  normal skin and using neural networks, a machine learning 
framework 32,33.  Additional in vitro studies have demonstrated the sensitivity of confocal 
RS to pilomatrixoma, a benign tumor of the hair follicles34, and demonstrated the ability 
of confocal RS to differentiate BCC and SCC4. Fiber optic probe based RS has been 
demonstrated capable of discriminating BCC from peri-lesional skin in the high-
wavenumber (2800 – 3125 cm-1). In vivo applications of RS for the detection of skin 
cancer has been limited to a study  using a handheld confocal RS probe to evaluate 
differences between BCC, SCC, inflammation, and normal skin35.  The results 
demonstrate the capability of Raman spectroscopy to perform differential diagnosis of 
cancerous skin pathologies in vivo.  
 
Fig.  11: In Vivo confocal Raman spectra. Grey bars indicate regions where spectral differences exist.35 
 
Qualitative differences in confocal Raman spectra acquired from 40 µm below the tissue 
surface indicate spectral differences between pathological samples at 920-940, 1000-
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1010, 1060-1070, 1250-1330, 1445, and 1650 cm-1. The data was classified with an 
algorithm using a non-linear machine learning algorithm to perform classification of 
tissue types with a 95% overall accuracy. Taken as a whole, the body of work in RS for 
skin cancer classification indicates the strength of the technique to perform highly 
specific classification of multiple cancerous and norn-cancerous tissue types with high 
accuracy.  
Optical Coherence Tomography 
  Optical Coherence Tomography (OCT) is a recently developed imaging modality 
capable of generating cross-sectional images of tissue micro-structure 36, function 37, and 
optical properties 38-40. The scale of conventional OCT images is on the order of low-
magnification histology with imaging resolutions generally better than 25 µm’s. In vivo 
applications of OCT are extensive, and include imaging of the eye 41-43, GI tract 44, and 
coronary vasculature 45.  
OCT –Theory 
In principle, OCT can be considered analogous to an optical version of 
ultrasound. While ultrasound images are formed by a transducer emitting ultrasonic 
pulses and then time gating detection of the tissue echoes, OCT images are formed by 
using an interferometer to correlate continuous wave light reflected from a reference 
mirror at a known distance with light reflected from a highly scattering tissue sample at 
an equivalent distance36. Both techniques essentially time gate a signal backscattered 
from the tissue, only OCT utilizes low-coherence interferometry rather than pulse-echo 
delay measurements due to the extremely high speed of light.  
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Fig.  12: Low-coherence Michelson interferometer as used in time-domain OCT 
 
 A low-coherence Michelson interferometer forms the backbone of the 
conventional OCT system (fig. 12). Light originating from the source can be represented 
as the electric field √2 Ei (with the √2 term existing for convenience, as will be seen 
later), where; 
 Ei = Ai(ω,k) e –j(ωt – kz)               (1) 
Here, Ai(ω,k) is the amplitude of the electric field (Ei) of the broadband laser source, 
ω (rad/sec) is the angular frequency (ω = 2pic/λ, where c is the speed of light and λ = 
wavelength), k (m-1) is the propagation constant ( k = 2pi/λ), and z (m) is the distance 
along the optical axis. The electric field incident on the detector (Ed) can be related to the 
interference generated from the recombination of the electric fields from the reference 
(Er) and sample (Es) arm as; 
 Ed =  Er + Es 
      = )]2(exp[
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),,(),()]2(exp[
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s
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r
i kltjzkRkAkltjkA −−+−− ωωωωω          (2) 
With Rs(ω,k,z) being the wavelength and depth-dependent reflectivity of the biological 
sample, and lr and ls being the positions of the reference mirror and scattering element 
within the sample, respectively, with respect to the beamsplitter. The electric field is 
generally detected by an optical power photodetector such that the signal observed out of 
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the detector is proportional to the square of the electric field. Since the response times of 
photodiode detectors are far slower than the temporal oscillations in the electric field, the 
photodetector current output, id (A), is averaged in time (indicated below by brackets) 
and can be given as; 
 id = 2dEρ  
     = [ ]∫∞
∞−
∆++ dklkzkRzkRkA ssi )2cos(),(2),(12
)( 2ρ
          (3) 
Where ρ represents the detector responsivity (A/W) (with the inherent wavelength 
dependence implied) and ∆l indicates the pathlength difference between the reference and 
sample arms (lr-ls). It is important to note that the signal has both a DC component (the 
first two additive terms of eq. 3), which is proportional to the incident laser power Ai(k)2, 
and the sample reflectivity, Rs(k,z), as well as an AC component (the last term in eq. 3), 
whose amplitude is also proportional to the incident laser power and sample reflectivity, 
but whose phase is strictly a function of the optical pathlength difference between the two 
arms of the interferometer. This AC term; 
 id, AC = dklkzkRkP s∫
∞
∞−
∆ )2cos(),()(ρ             (4) 
(where the laser power spectrum P(k) = Ai(k)2), is the interference signal expected from a 
single scattering element at a specific depth in the sample.  The solution to eq. 4 has been 
previously evaluated for a Gaussian source spectrum of the form; 
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where ko is the source center wavenumber and the full-width, half-max (FWHM) of the 
source spectrum is ∆k = 2pi∆λ/λo2. The resulting expression as a function of pathlength 
mismatch is46; 
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where lc is the coherence length of the laser source, and is defined as; 
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In time-domain OCT, the reference mirror is scanned through a range of distances such 
that an interference pattern can be acquired as a function of ∆l. This interference pattern 
in equation 6 is an oscillator whose fringe spacing is related to the center wavenumber of 
the laser source and whose envelope is defined by the convolution of the sample 
reflectivity profile with the laser source spectrum. When the object in the sample arm is a 
single reflector, such as a mirror, the interference function acquired from scanning the 
reference mirror can be considered the one-dimensional impulse response function of the 
OCT system, known as an interferogram.  It is important to note that the width of the 
Gaussian envelope for a single scattering element in the sample arm is defined by the 
coherence length of the laser source, lc. From equations 6 and 7, it can be seen that as the 
FWHM of the laser source spectrum (∆k or alternatively ∆λ) increases, the coherence 
length decreases and the spread of the one dimensional impulse response function 
narrows. This is illustrated in figure 13, where the AC component of the photodetector 
current output (eq. 6) has been simulated for two laser sources; one with an infinite 
coherence length (top) and one with a short coherence length (bottom). This illustration 
demonstrates that the broader the bandwidth of the laser source used to illuminate the 
Michelson interferometer in OCT, the greater the depth resolution. Inconsistencies in 
dispersion between the reference and sample arm can degrade the depth resolution of an 
OCT imaging system.  
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Fig.  13: Coherent vs. Low-Coherence Interference. The interference pattern generated by a perfectly 
coherent (monochromatic) laser source (top) in a Michelson interferometer setup has no fall-off in intensity 
as the pathlength mismatch between the two arms is varied because constructive interference between the 
two beams of light will always occur at λ/2 intervals. The interference pattern generated by a low-
coherence (broadband) laser source still demonstrates constructive and destructive interference, with fringe 
spacing of λ/2. However, because the laser source is not monochromatic, the amplitude of the interference 
falls of as the pathlength mismatch increases as per equation 6.  
 
Regardless, the key difference between OCT and other optical imaging methods such as 
confocal microscopy or multi-photon microscopy, is that the depth resolution is 
dependent on the characteristics of the laser source and independent of the focusing 
geometry of the sample objective lens. This enables imaging with micron scale axial 
resolution without the need for high-NA focusing optics. 
 In Fourier-domain OCT, the reference mirror is held fixed and the photodiode in 
the detection arm is replaced with a spectrometer that disperses the light as a function of 
k. A CCD detector then detects the interference spectrum as; 
 )2cos(),()(2),()()()()( 2 klzkRRkPzkRkPRkPkEkI srsrd ∆++==         (8) 
The amplitude of the interference signal can then simply be calculated by taking the 
inverse Fourier transform of I(k), and discarding the excess data that results from the 
conjugate symmetry of the operation.  
 Two-dimensional OCT images are built up by transverse scanning the sample beam 
across the sample and false-color coding the amplitude of the backscattered interference 
(fig. 14). 
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Fig.  14: OCT image construction. Axial profiles of backscattered intensity vs. depth are generated 
by scanning the mirror in the reference arm, while 2-D image construction is performed by 
transverse scanning of the sample beam 8. 
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OCT of Skin Cancer 
 OCT has extensively been applied to the in vivo imaging of the skin to examine 
dermatitis, psoriasis, as well as the effect of varies ointments, water, tape stripping, and 
UV radiation on normal skin 47-51. A number of papers have demonstrated the potential 
utility of OCT for imaging skin cancers. A number of studies have reported the 
appearance of various types of skin cancer in OCT, including BCC and melanoma (fig. 
15). Tumor cell nests appear as dark, hypo-reflective regions. In melanoma, it is possible 
to identify the elongated rete ridges. Polarization sensitive - OCT (PS-OCT) imaging of 
BCC has been reported, and the results indicate that tumors alter phase retardation as 
function of depth52. Histomorphometric correlation between OCT and histology in BCC 
and malignant melanomas has been verified9, indicating the suitability of OCT to 
quantitatively assess Breslow thickness in melanomas, an important parameter for 
staging.  
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Fig.  15: OCT of BCC and malignant melanoma. The histology (A) and OCT (B) of a nodular BCC11. 
Histology (C) and OCT (D) of an infiltrating BCC11. Histology (E) and OCT (F) of malignant melanoma53. 
 
 Despite the high-resolution of OCT images, they remain difficult to evaluate to the 
untrained eye.  Recently, a Danish groups has undertaken the task of interpreting and 
classifying OCT images of BCC and actinic keratoses (AK). Jorgensen et. al. identified a 
number of image features related of BCC and AK, labeled a set of 78 lesions from 34 
patients according to these features, and attempted to perform classification of the images 
24 
with support vector machine learning algorithm. The study reported a classification 
accuracy of 81% for BCC and 73% for AK. Mogensen et. al. undertook the task of 
training a group of pathologists and dermatologists to visualize the morphological 
features of OCT and PS-OCT images of BCC, AK, and normal skin on a training set of 
50 images, and then asked the physicians to classify > 200 images, with nearly half 
normal and the remaining half split approximately 60:40 BCC:AK. The results indicated 
that the best, most experienced observers could distinguish BCC from normal skin quite 
well, with a sensitivity of ≈ 80% and a specificity of ≈ 95%.  AK and BCC, however, 
were virtually indistinguishable due to their similar morphological appearance in OCT. 
These results indicate the strength of OCT in visualizing features of disease with high 
sensitivity, but the inability to distinguish AK from BCC indicate the low specificity to 
disease class.   
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Abstract 
Skin cancer is the most commonly occurring of all cancers, and its incidence is growing. 
Realizing favorable outcomes requires early diagnosis, for which the current gold 
standard is biopsy followed by histopathology. This process can be invasive, subjective, 
time consuming, and costly. Raman spectroscopy is a non-invasive optical technique 
capable of characterizing the biochemical composition of skin and performing disease 
classification based on statistical methods. Here, we demonstrate the potential utility of 
fiber optic probe based Raman spectroscopy for the in vivo diagnosis of non-melanoma 
skin cancers. Patients scheduled to undergo routine removal of skin lesions were enrolled 
in the study. Measurements were made from the lesion center and perilesional normal 
skin of 34 lesions (18 BCC/SCC, 16 non-cancerous inflammation/scar). Difference 
spectra (lesion – perilesional normal) were calculated to account for the natural variation 
of Raman skin spectra. A spectral classification algorithm was developed with Sparse 
Multinomial Logistic Regression (SMLR). Using leave-one-patient out cross validation, 
Raman spectroscopy was able to perform non-invasive diagnosis of disease with a 
sensitivity of 78 % and a specificity of 94%, indicating the potential utility of the 
technique for skin cancer diagnosis. 
 
Introduction 
Skin cancer is the most commonly occurring of all cancers, accounting for more 
than a 1.7 million incidences in the United States annually1. In addition, the incidence 
rate for skin cancer is growing, particularly among young Caucasian women aged 15-34 
(3.8% annually) and Caucasian men aged over 65 (8.8% annually)1.  Realizing good 
outcomes for patients with skin cancer relies on early detection. The two most common 
types of skin cancer, basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), 
are highly curable if detected at an early stage.  Although the most dangerous skin cancer, 
malignant melanoma, can have a 5 year survival rate of only 16% at its most advanced 
stage, cases detected in situ have survival rates of 99%1. The current gold standard for 
screening and detection is visual inspection followed by biopsy and histopathology. 
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Visual inspection can be difficult and it is often easy to overlook disease. In many cases, 
biopsy or preemptive removal of a large number of lesions can serve as a simple solution; 
however this approach is subjective, invasive, time-consuming, and costly. Based on a 
2005 estimate, the total negative skin cancer biopsies outnumber non-melanoma and 
melanoma diagnoses by approximately 40:12. Assuming the average direct cost of biopsy 
and histology to be $500 in the US, the cost of negative biopsies can be roughly 
estimated at $30 billion. Despite the fact that morbidity due to skin cancer is low, it is 
clear that the benefit of accurate, non-invasive diagnosis of skin cancer have a significant 
impact on patient comfort and the overall cost of skin cancer management. 
 Optical techniques are one approach for non-invasive skin cancer diagnosis. A 
number of imaging-based techniques including optical coherence tomography3 and 
confocal microscopy4 are capable of visualizing the microstructural features of disease, 
however the qualitative nature of image analysis and the lack of molecular specificity can 
make accurate disease classification difficult. Spectroscopic techniques can be considered 
advantageous due to their inherent molecular specificity and the quantitative nature of 
spectral analysis.  Fluorescence spectroscopy has shown promise for non-invasive 
detection of skin cancer5, however intrinsic fluorophores in the UV-visible spectrum are 
limited to NaDH, FAD, and porphyrins, which can constrain tissue classification. Novel 
approaches utilizing near-infrared two-photon excitation to isolate melanin fluorescence 
from the tissue background6 are beneficial specifically for the challenge of melanoma 
detection, however they cannot be generalized for the detection of all skin cancers.  
Raman spectroscopy is a technique that probes molecules on the vibrational level. 
The relative shift of the in-elastically scattered light contains information related to the 
specific molecular composition of the sample. In particular, the Raman fingerprint region 
from 500 to 2000 cm-1 contains features characteristic of wide range of biomolecules, 
including nucleic acids, lipids, collagen and other proteins. In comparison with 
fluorescence or diffuse reflectance spectroscopy, Raman spectroscopy has been 
demonstrated to perform detection of cancer with superior specificity and overall 
classification accuracy7. In vivo, Raman spectroscopy has been demonstrated capable of 
detecting cancers in tissues such as the cervix8 and gastrointestinal (GI) tract9.  
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In the skin, a number of in vitro studies have demonstrated the diagnostic 
potential of confocal Raman spectroscopy or Raman micro spectroscopy. Nijssen et. al. 
demonstrated the ability of Raman spectroscopy to differentiate BCC from the 
surrounding dermis and epidermis, as well as detect subtle changes within the 
peritumoral dermis associated with inflammation and changes in collagen content10.  The 
molecular specificity of Raman was highlighted in a study by Lieber et. al. which 
reported direct multi-class separation of normal skin, BCC, SCC, and melanoma with a 
non-linear Bayesian classification algorithm11. Fourier-Transform Raman spectroscopy in 
combination with neural networks further demonstrated the ability to perform 
classification of skin cancers from non-malignant lesions such as benign pigmented nevi 
and seborrheic keratosis12, 13. Confocal micro-spectroscopy with spatial resolution of 1 
µm has detected differences between the nuclei of BCC cells and normal epidermal cells, 
further underscoring the biochemical specificity of Raman spectroscopy14. Recently, the 
diagnostic potential of Raman micro-spectroscopy was validated by a study that 
performed in vivo measurement of skin lesions with a handheld device and was able to 
separate normal skin, BCC, SCC, and inflamed scar tissue with a 95% overall 
classification accuracy15.  
The motivation behind previous work utilizing confocal Raman spectroscopy has 
been to isolate signal arising from cancerous cells by rejecting contributions from the 
epidermis and focusing directly on the cancer cells of interest. Theoretically this is ideal, 
however there are a number of reasons to believe such an approach may not be necessary. 
First, previous studies using contact fiber-optic probes with non-confocal collection 
geometries have been demonstrated effective for the detection of cancer in the cervix and 
GI tract, both of which are epithelial tissues that follow a pathological progression to 
cancer similar to the skin. Secondly, there are a number of reports that demonstrate the 
sensitivity of Raman spectroscopy to peritumoral changes in the dermis10, 14, 16. In the 
clinical study performed by Lieber et. al., all measurements were acquired from a depth 
of 40 µm below the tissue surface due to the impracticality of performing a full-depth 
scan on each lesion. Follow up histopathology indicated the depth of tumor cell nests 
varied significantly and in most cases was far below the depth probed. The excellent 
classification accuracy reported in the study suggests that going to great lengths to 
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acquire light scattered from tumor cells may not be necessary for the purposes of 
diagnosis. In particular, non-contact confocal collection geometries require much longer 
integration times (approx. 30 sec) due to rejection of out-of-plane light and less efficient 
light transmission through the optical system in the absence of index matching. Fiber 
optic probes, on the other hand are much more efficient and capable of collecting spectra 
in approximately 3 sec, which greatly simplifies clinical collection of spectra. 
Classification of BCC from normal tissue using a non-confocal fiber-optic has recently 
been demonstrated in vitro17. This study only collected the high-wavenumber (2800-3125 
cm-1) Raman shift band, a region that can be dominated by contributions from collagen 
and contain less distinctive features than the fingerprint region17.  This goal of this study 
is to assess the performance of fiber-optic probe based Raman spectroscopy for in vivo 
skin cancer diagnosis. 
  
Materials and Methods 
Raman Instrumentation 
 A schematic diagram of the fiber optic probe Raman system is illustrated in figure 
2.1. A 785 nm multi-mode laser diode (Innovative Photonics Solutions, Inc.) is coupled 
into a 7 collection-around-1 illumination fiber optic probe (Visonex). The illumination 
fiber is a 400 µm low-OH fiber. Within the probe is a 785 nm in-line filter that reduces 
Raman scatter generated within the fiber. For each measurement, the laser power at the 
sample was set to 80 mW. The 7 300 µm collection fibers are angle polished and thus 
steer the collection geometry towards the optical axis of the illumination fiber for more 
efficient collection in the near-field. The fiber probe contains in-line 785 nm notch filters 
in each of the collection fiber optical paths to reduce elastic scatter and thus further 
minimize Raman signal generated in the fiber optic probe. The collection fibers are re-
arranged into a vertical line at the entrance to the spectrograph in order to best fill the 100 
µm slit. Within the spectrograph the light is again notch filtered. A back-illuminated, 
deep-depletion, thermo-electrically cooled CCD camera detects the light and relays the 
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data to a laptop computer for processing. The spectral resolution of the detection is 7.7 
cm-1.  
 
Spectrograph
CCD
785 nm
7
300 µm
fibers
400 µm
fiberBPfilter
Notch
filters
 
Fig.  2.1: Fiber Optic Probe based Raman Spectroscopy System. A 785nm source is fiber coupled to a 
fiber optic probe that delivers 80 mW of light to the sample. The 7-around-1 fiber probe contains in line 
notch and band pass (BP) filtering to minimize Raman resulting from the fiber, and minimize collection of 
elastic scatter.  
Study Protocol 
All procedures for patient enrollment, informed consent, experimental protocol, 
and specimen collection / retention were approved by the Vanderbilt University 
Institutional Review Board. 
All patients presenting at the Vanderbilt dermatology clinic scheduled for routine 
resection of skin lesions previously identified as cancerous via pathology were eligible 
for enrollment. Fiber probe and lesion surface were swabbed with alcohol prior to 
measurement. Three (3) Raman spectra were acquired from within the visible clinical 
margins of the lesion (as determined by the physician performing the resection), and 3 
spectra were acquired from adjacent normal skin within the planned excision boundary. 
After each measurement, the position of the probe tip was marked with ink, and a 2mm 
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punch biopsy was taken from both the lesion and normal skin measurement sites for 
correlation with Raman measurement. All spectra were acquired in < 5 seconds per 
acquisition. In total, 42 patients were enrolled in the study, with 45 lesions measured. 
Spectral Pre-processing 
Prior to each day’s data collection, the spectral dispersion of the detection system 
was calibrated using the atomic emission lines of a neon-argon lamp, and variations in 
spectral throughput of the system were calibrated using a NIST-certified quartz-tungsten-
halogen lamp. Relative Raman wavenumber shift was calibrated with acetaminophen and 
naphthalene standards. Data was binned to ½ the spectral resolution, high frequency 
noise was removed with a 2nd order Savitzky-Golay filter with a window size twice the 
spectral resolution. Finally, background tissue autofluorescence was subtracted with a 
modified polynomial fitting algorithm18, and the resulting spectra were area normalized 
in order to maintain potentially relevant information from all peaks. The 3 spectra from 
each measurement location were averaged to produce a single spectrum per position.   
Data Analysis 
Due to the high heterogeneity of skin, all analysis was performed on difference 
spectra, calculated as; lesion mean spectrum – adjacent normal mean spectrum. Despite 
the fact that each patient had a pathologically confirmed skin cancer prior to enrollment, 
in some cases the initial biopsy used for diagnosis actually removed the entire cancer, 
leaving behind normal scar tissue. Thus, our data set included 3 classes; inflammation / 
scar (non-cancerous), BCC, and SCC. In order to qualitatively determine spectral ranges 
where differences between all classes of lesion (defined as scar/inflammation, BCC, and 
SCC) spectra and normal spectra were present, the pooled standard error of all the data 
was calculated as a function of wavenumber15. Spectral bands falling outside the normal 
standard error were deemed to be significant. Analysis was performed on the data 
stratified into simply 2 classes; inflammation / scar (non-cancerous) and cancerous (BCC 
and SCC) due to the limited sample size. Here, the standard error of just the normal data 
was calculated to determine significantly different spectral bands. 
 Quantitative analysis was performed with Sparse Multinomial Logistic 
Regression (SMLR), an algorithm based on the sparse Bayesian machine-learning 
36 
framework of statistical pattern recognition19. The algorithm operates on weighted basis 
functions with sparsity promoting prior terms that drive basis functions to significance or 
zero. The algorithm then uses a multinomial logistic regression model to construct 
decision boundaries that optimally separate data classes.  The output of SMLR is a set of 
predicted posterior probabilities of class membership for each input spectrum. The 
probability of membership to class, i, of each basis function, x, is given in equation 2.1. 
 
 
Equation 2.1: Probability of Class Membership in SMLR19. 
 
Optimization and sparsity promotion of the weight vector, w, is the primary advantage of 
SMLR. The promotion of sparsity is a critical feature for generalizability, based on 
machine learning theory. Spectral classification is assigned to the class with the highest 
posterior probability. 
Results 
Representative pathology sections used for the assignment of tissue class are 
shown in figure 2.2. In total, 34 lesions from 32 patients were retained of the 45 
measured lesions, with 14 from BCC, 4 from SCC, and 16 from scar/inflammation. 
Lesions were excluded due to instrumentation variations that introduced systemic bias in 
the data (5), errors in pathological processing that resulted in unclassifiable tissue 
specimens (2), spectra with large, non-Raman features (i.e. fluorescent lighting, cosmic 
rays) that could not be removed without skewing the data(3), and a lesion in which the 
operating physician was unable to perform a biopsy of the peri-lesional normal 
measurement site due to a change the resection plan(1). 
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Fig.  2.2: Representation Histopathology of tissue samples acquired at Raman spectroscopy 
measurement sites. The heterogeneity of normal skin (a) is seen in the presence of sebaceous glands (SB) 
and hair follicle (HF) cross sections (10x). Scar tissue and inflammation has distinct features, including a 
relatively flat epidermal-dermal junction, predominantly horizontal arrangement of the collagen network, 
and the presence of dark staining inflammatory cells dispersed throughout the dermis (10x). BCC (c, 4x) 
features include the presence of clear basophilic tumor cells nests with nuclear atypia. SCC tumor cells, in 
contrast, are typically eosinophillic, but also contain atypical nuclei as identified (d, 10x). 
 
The mean spectra from the lesions retained for analysis are shown in figure 2.2. 
The grey region indicates the variance of normal skin spectra. The spectral features 
observed in the data as a whole are generally similar to those reported in literature of 
Raman spectroscopy in the skin. The spectral feature near 849 cm-1 has been attributed to 
the amino acid tyrosine20. The peak at 940 cm-1 is attributed to the C-C stretch in 
hydroxyproline and collagen21. The 1003 cm-1 peak is commonly assigned to 
phenylalanine ring breathing10, 20, 22. The 1076 cm-1 peak is attributed to PO2 symmetric 
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stretching present in both lipids and nucleic acids10, 20, 22. The 1265 cm-1 peak is attributed 
to C-N stretching in amide III20, 22. The 1304 and 1444 cm-1 peaks are assigned to CH2 
modes that are common in a number of molecules including lipids, proteins, adenine, and 
cytosine10, 20, 22. The 1667 cm-1  peak is attributed to the C=O stretch in amide I10, 20, 22. 
Note that in large part, all lesion types lie within the normal spectra variance, indicating 
that direct classification will likely be difficult.  
 
 
Fig.  2.3: Mean spectra from measured tissue classes. Grey area indicates the 95 % confidence intervals 
based on calculation of the standard error the normal spectra. Note that all lesion types predominantly lie 
within the variance bounds of normal skin spectra, making direct classification of spectral differences 
difficult.  
 
The lack of clear visible distinction between lesion spectral classes is expected 
because skin is a very heterogeneic tissue, and can have varying epithelial thickness, 
dermal structure, glandular content, that can contribute as sources of variance in the 
spectra. This heterogeneity can be accounted for by subtracting the lesion spectra from 
the normal spectra. The mean difference spectra for cancerous lesions and 
scar/inflammation are shown in figure 2.4. The grey area indicates the 95% confidence 
intervals, which are calculated from the variance in normal skin spectra. The plots are 
shown to provide some indication of what features are likely to contribute to the 
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classification. The difference spectra for scar/inflammation tissue does not stray outside 
the confidence intervals in any wavenumber region. The cancer difference spectra, 
however, are distinctly different at a number of spectral areas. There is a significant 
increase in the bands from 999 to 1010 cm-1, 1203 – 1215 cm-1, 1639-1647 cm-1, and 
1785-1789 cm-1. Although the mean difference spectra for the two lesion types still 
mostly fall within the variable range of normal skin spectra, there are clearly some 
features that the classification algorithm may utilize.  
 
 
Fig.  2.4: Mean difference (lesion – normal) spectra. Grey area indicates the 95% confidence intervals 
for normal skin plotted about 0. Black arrows indicate locations where spectra is outside the confidence 
intervals. Green arrows indicate that are nearly beyond the confidence interval bounds and utilized by 
SMLR for classification. 
 
The SMLR algorithm generated a sparse set of basis functions to represent the 
difference spectra and provide optimal classification accuracy using the wavenumber 
points shown in table 2.1.  The results of the leave one patient out cross validation of the 
learned classification algorithm are shown in table 2.2. The sensitivity and specificity are 
78% and 94%, respectively. The overall classification accuracy is 85%. The receiver 
operating curve is shown in figure 2.5a. The area under the curve is 0.85. Figure 2.5b 
shows a map of the calculated posterior probabilities of the correct class membership for 
each sample. A probability of 0.5 was set as the decision threshold. Misclassified 
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cancerous lesions were; 1.) a 66 year old male with a BCC of the nose, 2.) a 49 year old 
female with a BCC of the forehead, 3.) an 83 year old female with a BCC of the scalp, 
and 4.) a 48 year old female with a BCC of the mandible. The lone scar/inflammation 
lesion that was misclassified was taken from the shoulder of a 61 year old female at a 
location that was previously SCC. 
 
Slope of CHx peak (Protiens, Lipids)
Slope of Amide III peak (Lipids, various proteins)
Slope of C-C stretching, trans peak (Lipids)
Slope of Phenylalanine ring breathing peak (DNA, Proteins)
Slope of Phenylalanine ring breathing peak (DNA, Proteins)
PO2 symmetric stretching (DNA, RNA) 
Involved Peak Assignment
Significant1776
Nearly Significant1535
Nearly Significant1430
1391
1297
1129
Significant1010
Significant1006
Nearly Significant786
SignificanceWavenumber (cm-1)
 
Table 2.1: Spectral Features Utilized by SMLR classification algorithm. The 2nd column indicates if the 
feature falls outside the 95% confidence intervals of normal spectra as shown in figure 4. The 3rd column 
indicates if the data point is involved in any prominent peaks of skin spectra. 
 
 
151Scar / Inflammation
414Cancer
Scar / 
InflammationCancer
 
Table 2.2: Classification Results. 
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Fig.  2.5: Classification Results. (a) Receiver Operating Curve. Area under the curve = 0.85. (b) is a map 
of each samples posterior probabilities membership to the correct class. Probability of 0.5 was the decision 
threshold. 
 
Discussion 
 The results indicate the potential of fiber probe based Raman spectroscopy for in 
vivo skin cancer diagnosis. There is a significant difference in the band from 999 to 1010 
cm-1, which corresponds to the phenylalanine peak and indicates increased contribution 
from proteins/nuclei. This band is also identified by the SMLR learning algorithm as 
containing 2 of the 9 points used for classification, further indicating its diagnostic 
relevance. Although the spectral features at 786 and 1430 cm-1 do not lie beyond the 95% 
confidence intervals of normal spectral variance, they are near the boundary and 
identified by SMLR as diagnostically relevant. The 786 cm-1 spectral feature appears as 
the shoulder of the larger 849 cm-1 protein peak, however in the difference spectrum is 
more distinct. Njissen et. al. have observed this peak in previous work identifying BCC 
with Raman spectroscopy and attributed it to DNA and RNA10, making it a likely band to 
be identified for diagnostic relevance. The 1430 cm-1 feature can be indicative of the 
width of the CH2 peak at 1444 cm-1. This region has been previously implicated as 
diagnostically relevant in skin cancers10, 15, however the fact that it contains contributions 
from a wide number of lipid and protein subgroups makes commenting on the biological 
relevance difficult. On the whole these spectral features identified by the SMLR machine 
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learning classifier point towards increased protein, DNA, and RNA content driving 
classification performance.   
The 1203 – 1215 cm-1 and 1639-1647 cm-1 bands, on the other hand, contain 
significant differences, however, they are not identified as critical in classification. This 
does not necessarily indicate these bands will not be relevant in future classification 
algorithms that would likely seek to classify between cancer subclasses. The SMLR 
algorithm is designed to seek out the sparsest basis functions possible for classification 
performance, and it is possible these features may have been redundant to other features 
identified.  
Overall, the diagnostic accuracy achieved from the data in this study is not up to 
the standards reported in the Raman skin cancer literature. The lone reported in vivo 
study by Lieber et al. achieved an overall classification accuracy of 95% (n = 21) in 
which 4-way classification of normal skin, BCC, SCC, and inflammation/scar was 
performed. A number of in vitro studies of non-melanoma skin cancer detection with 
Raman spectroscopy have all demonstrated overall classification accuracies in excess of 
90% 10, 12, 16. The critical factor all these studies utilized was a confocal collection 
geometry that allowed isolation of Raman scattered light originating in the dermis from 
the epidermis. Lieber et. al. were able to achieve high classification accuracy by summing 
spectra from depths ranging from the surface down through 100 µm, implying that a 
confocal collection geometry was not necessary, however this sum is evenly weighted 
across all depths. The fiber-optic probe utilized here is bound to collect a spectrum that is 
surface biased for two reasons. The first is the beam-steered angle polish of the collection 
fibers will observe light scattered from the tissue surface directly infront of the probe 
preferentially to the underlying dermis. A more appropriate probe to use for a skin cancer 
detection study may be one without beam steered collection fibers that collect from a 
wider range of depths. Nevertheless, these results seem to warrant a direct side-by-side 
test of the classification accuracy of a fiber-probe based Raman system with a confocal 
collection system to determine which performs superior classification.  
Alternatively, the inferior classification accuracy seen in the current study may be 
strictly due to an insufficient sample size. The appropriate manner in which sample size 
should be calculated is with respect to the statistical test being performed for 
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classification. If the test being performed is a simple t-test of the 1003 cm-1 peak, the 
appropriate sample size for this study is n = 56 (sample mean and standard deviation 
calculated from data in this study, α = 0.05, power = .95). With 34 patients currently 
enrolled, and an α of 0.05, the power of the study (probability of correctly rejecting the 
hypothesis that the mean values of the phenylalanine peaks are the same) can be 
calculated as 0.823. Clearly, this approach is not appropriate given the approach we are 
taking for classification is SMLR. Ultimately, the appropriate sample size for the SMLR 
test needs to be performed. However, given the fact that the SMLR test is likely more 
sensitive, these figures should provide a conservative estimation for the necessary 
enrollment figures.  
Previous work using fiber-probe based Raman spectroscopy in the cervix has 
identified the technique’s sensitivity to biological phenomena that are not readily visible 
in histology8. Hormonal factors related to a woman’s ovulatory status were determined to 
significantly affect the classification performance of a Bayesian classifier similar to the 
SMLR algorithm used in this study. Based on these results, it is possible that stratifying 
the data appropriately may assist classification performance. Analysis of available data 
related to the patients enrolled in this study (age, gender, lesion location) did not bring 
any obvious patterns to light. The misclassified lesions were from male and female 
patients of a wide range of ages, and from a wide range of locations, none of which were 
exclusive to misclassification. In the case of skin cancer, however, one confounding 
factor worth investigating is the patient’s organ transplant history. It is known that organ 
transplant recipients have greatly increased (approx 65-fold) incidence of skin cancer due 
to their immuno-compromised status24.  In Vanderbilt Mohs Surgery, where a majority of 
the patients for this study were recruited, roughly 1/3 of the patients are organ transplant 
recipients. It is possible that stratifying the patients according to this patient history factor 
may improve classification performance. 
Ultimately, the sources of variability in normal skin are many, and the appropriate 
application of a technique with the biochemical sensitivity of Raman spectroscopy 
requires further investigation. Here, we have demonstrated that fiber probe based Raman 
spectroscopy shows promise for non-invasive detection of cancer from non-cancerous 
lesions. In contrast to a previous in vivo study utilizing a confocal collection geometry, 
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the shorter spectral integration times and the physical ease of handling a fiber-probe are 
definite advantages for practical clinical implementation. The future directions for this 
work include recruiting more patients and assessing the patient history for possible 
sources of variation. 
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Abstract 
We report a dual-modal device capable of sequential acquisition of Raman Spectroscopy 
(RS) and optical coherence tomography (OCT) along a common optical axis. The device 
enhances application of both RS and OCT by precisely guiding RS acquisition with OCT 
images while also compensating for the lack of molecular specificity in OCT with the 
biochemical specificity of RS. Here, we characterize the system performance and 
demonstrate the capability to identify structurally ambiguous features within an OCT 
image with RS in a scattering phantom, guide acquisition of RS from a localized 
malignancy in ex vivo breast tissue, and perform in vivo tissue analysis of a scab.  
Letter 
Optical imaging and spectroscopy have both been used to detect disease based on 
analysis of tissue microstructure and biochemical composition, yet neither method has 
demonstrated the spatial sensitivity and rapid data acquisition needed for screening in 
combination with the high specificity required for reliable multi-class discrimination. 
Spectroscopy excels at detecting molecular markers of disease with high specificity, while 
imaging excels in detecting tissue microstructure with high sensitivity. In particular, near 
infrared (NIR) Raman spectroscopy (RS) has been used for in vivo detection of cancers in 
various organs [1]. RS is sensitive to vibrational modes in tissue and produces fingerprint spectra 
characteristic of specific molecules and their environments, thus realizing unparalleled molecular 
specificity. A recent comparison of Raman, fluorescence, and diffuse reflectance spectroscopy 
for breast cancer detection demonstrated the superior specificity of RS in classifying disease [2]. 
The weak nature of RS requires integration times of 3-30 seconds, limiting the technique to point 
measurements and motivating the need for image guidance to improve sampling accuracy. A 
combined confocal microscopy (CM) – confocal RS device was developed to guide RS 
acquisition with images of tissue microstructure [3], but confocal imaging depth in epithelial 
tissues is limited to ≈ 250 µm and transverse field-of-view (FOV) is limited to ≈ 500 µm. 
Combining the molecular specificity of RS with an imaging method that has increased depth and 
larger FOV will yield a valuable tool for early detection of disease.  
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Optical coherence tomography (OCT) can image over larger transverse areas of tissue (> 
5mm) with micron scale resolution, real-time speed, and sensitivity to microstructural features of 
disease [4]. The primary limitation of OCT is that the images are reflectivity maps of sample 
morphology but lack biochemical specificity. For instance, differentiating between a benign 
pigmented skin lesion and superficial spreading melanoma can be difficult due to similar 
irregular morphology of the epidermis in both cases [5]. Just as RS would benefit from image 
guidance, OCT would benefit from biochemical specificity for classifying irregular structures. A 
number of intrinsic and extrinsic approaches to add molecular contrast directly to OCT are being 
evaluated by many groups [6]. One of these is an OCT system capable of detecting coherent anti-
stokes RS (CARS) [7]; however, CARS requires a much costlier laser source than NIR RS and 
currently has limited clinical translatability. Another approach is to combine complementary 
modalities of molecular contrast with OCT such as an OCT-fluorescence device [8].  However, 
the higher specificity of RS makes it a better choice for detecting disease. The complementary 
natures of RS and OCT were demonstrated in a study where two separate instruments were used 
to analyze the microstructural and biochemical features of dental carries [9]. This work suggests 
the benefit of a single device capable of RS and OCT for complete tissue characterization. 
In this letter, we present a dual-modal RS-OCT device capable of sequentially acquiring 
NIR RS and OCT data through common sampling optics, while keeping the source and detection 
arms separate. This system allows each technique to compensate for the limitations of the other; 
OCT imaging can be performed in real-time and used to guide the measurement of a Raman 
spectrum from an area of 600 µm in depth by 75 µm across along the central axis of the OCT 
image. Raman spectra can be acquired to specifically characterize the biochemical fingerprint of 
ambiguous structures within an OCT image. Conversely, OCT can rapidly perform 
microstructural imaging of large areas and precisely guide the acquisition of RS from tissue. The 
capabilities of RS-OCT are demonstrated in scattering phantoms, ex vivo tissue, and in vivo skin. 
The instrument setup is shown in figure 3.1. A 1310 nm (∆λFWHM = 60 nm) OCT source 
is coupled into a fiber Michelson interferometer with a circulator in the source arm to enable 
balanced detection [10]. A 50/50 fiber coupler splits the light into the reference arm [11], and the 
sample arm, where an XY galvanometer pair scans the light across an achromatic doublet 
objective lens (f=35.0 mm, NA = 0.36) to generate B-scans. The detected interference signal is 
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band-pass filtered, amplified in hardware, and digitized at 1.25 Msamples/s. Demodulation and 
logarithmic compression are performed in software prior to live display of the grayscale image. 
 
 
Fig.  3.1 Diagram of RS-OCT system. C–Circulator, RSOD-Rapid Scanning Optical Delay, BP–785 Band Pass, 
BSO–Beam Shaping Optics, DM1–Dichroic Mirror at 990 nm, DM2–Dichroic Mirror at 800-950 nm, LP–Long 
Pass at 808 nm,   GP–Galvanometer Pair, BD–Balanced Detector, BPF–electronic Band Pass Filter, AI/AO DAQ–
Analog Input/Output Data Acquisition. 
 
The Raman source is a 785 nm diode laser that is directed through a magnifying lens pair 
that spatially filters and shapes the beam to produce a Gaussian profile. The OCT and Raman 
incident beams are co-aligned by a dichroic mirror (DM1), and then redirected to the sample by a 
second dichroic mirror (DM2) that reflects both source beams while transmitting the Raman 
stokes band. The XY galvanometers are fixed and RS is performed only along the central axis of 
the objective lens. The Raman laser power at the sample is fixed at 40 mW. For Raman 
detection, a long-pass filter reduces Rayleigh scatter and an achromat (f=19.0 mm, NA=0.33) 
couples the Raman scatter into a 100 µm core low-OH fiber which acts as a pinhole. An f/1.8 
holographic imaging spectrograph with an integrated 785 nm notch filter disperses the light onto 
a back-illuminated, deep depletion thermo-electrically cooled CCD camera. The spectral 
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resolution of the system is 7.7 cm-1. System calibration and processing are performed using a 
quartz tungsten halogen lamp, neon-argon lamp and Raman standards (described in [12]). 
All OCT images were acquired with a line rate of 500 Hz and scan range of 2.4 mm at 1 
frame/s. The OCT signal-to-noise (SNR) is 125 dB with a mirror as the sample.  The measured 
axial and lateral resolutions are 21 µm in air (15 µm in tissue) by 25 µm, respectively. The 
average Raman SNR of an RS standard such as naphthalene was found to be 57 dB with 1 
second integration.  The RS point-spread function (PSF) was found to be 600 µm axially and 75 
µm laterally at FWHM. This was obtained axially by measuring the 1308 cm-1 peak intensity of a 
12.5 µm layer of polyethylene as a function of its axial position in the OCT image and 
transversely by measuring the falloff in Raman intensity while translating across a clean edge of 
the polyethylene placed at the focus of the axial PSF. To verify the co-alignment of the Raman 
and OCT beams, a gelatin phantom was placed at multiple depths in the OCT image, and a 
dehydrated indentation in the surface of the sample was created with the Raman laser at high 
power. An OCT image of the indentation verified the transverse position of the Raman beam. A 
vertical targeting line at this position was overlaid onto the OCT image to guide positioning of 
the area of interest for RS, and horizontal targeting lines corresponding to the FWHM of the 
axial PSF were overlaid for axial alignment (see fig. 3.2). All samples were placed on a 
translation stage and Raman spectra were obtained by positioning the area of interest in the 
sample within all three targeting lines. Figures 3.2-3.4 each display an overview OCT image of 
the sample; the vertical lines in these figures identify the transverse position where Raman 
spectra were acquired. The horizontal lines that guide the depth of RS acquisition are not shown. 
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Fig.  3.2: RS-OCT from a scattering gel with BMSB (solid line) and naphthalene (dashed line) showing similarities 
in OCT but biochemical differences in RS. Scale bar is 0.8 mm. An example of the red Raman targeting lines are 
shown. Scattering in the sample is due to 1µm polystyrene microspheres, whose spectral contribution can be seen 
from the peak at 1001 cm-1. 
 
A scattering gelatin phantom containing two Raman active crystals (naphthalene and 1,4-
Bis(2-methylstyryl)-benzene (BMSB)) with similar optical and structural properties was used to 
demonstrate the ability of RS to aid OCT (fig. 3.2). Although the two crystals appear similar in 
OCT, RS of the left crystal contains the BSMB peaks at 1181, 1206, 1594, and 1629 cm,-1 while 
the right crystal shows naphthalene peaks at 513, 765, 1024, 1381, and 1577 cm-1.   
The ability of OCT to screen tissues and guide RS was demonstrated with an ex vivo 
malignant human breast tissue sample (Fig. 3.3). The tissue was scanned with OCT to locate 
highly scattering abnormal regions, one of which was surrounded by normal fatty tissue. The 
OCT display was used to guide collection of Raman spectra from both the abnormal and normal 
sites. The spectral lineshapes are characteristic of reported normal and malignant breast tissues 
[2], with the normal spectrum dominated by lipid signatures and the malignant spectrum 
demonstrating greater DNA and protein content, especially collagen.  The size of the malignant 
region in Fig. 3.3 was only ≈ 500 µm, yet OCT allowed sample localization and confirmed that 
spectra were acquired from the correct transverse position. 
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Fig.  3.3: RS-OCT of normal (dashed line) and malignant (solid line) ex vivo breast sample where structural 
anomaly in OCT is spectrally characterized by pronounced protein peaks indicative of malignancy while normal 
breast shows a strong lipid signature. Scale bar is 500 µm. 
 
The applicability of RS-OCT for in vivo tissue characterization was demonstrated by 
evaluating a healing wound on the finger of a volunteer (fig. 3.4). The scab is visible in OCT as a 
hyper-reflective region in the center of the image. Immediately adjacent to the scab is a region 
with epidermal disruption that is likely due to remodeling. The finger was positioned with OCT 
such that RS could be acquired from the center of the scab and the peripheral wound. Three 
spectra from each position were averaged, yielding an in vivo SNR of 33 dB at the 1440 cm-1 
peak.  Subtle differences in the spectral line-shapes were observed, including the 856 and 940 
cm-1 collagen peaks in the scab spectrum.  
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Fig.  3.4 In vivo RS-OCT of a scab (dashed line) and peripheral wound (solid line) on the back of the finger.  Scale 
Bar is 1mm. Inset picture shows wound and direction of scan. Arrows identify increased collagen peaks in scab 
spectrum. 
 
This Letter presents the 1st combined NIR RS-OCT device that demonstrates the potential 
advantages of morphological and biochemical evaluation of tissues. The goal of our work is the 
application of RS-OCT for diagnosis of epithelial cancers; however, thorough tissue 
characterization with RS-OCT could benefit other applications. The Raman collection 
throughput can be improved with filter and dichroic mirror redesign, reducing in vivo integration 
times to < 10 seconds. The axial resolution of RS could be improved to approach that of OCT 
with true confocal detection, but the sharp focus of the incident beam in such a system would 
degrade OCT transverse resolution away from the focus. Using a common wavelength for RS 
and OCT would further simplify the RS-OCT system, but attempting RS at wavelengths closer to 
1310 would result in weaker scattering and thus longer integration times. Alternatively, OCT can 
be performed in the 800 nm band, but increased scattering would reduce imaging depth. This 
system therefore presents a compromise for optimal performance from both modalities. 
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Abstract 
Raman spectroscopy (RS) and Optical Coherence Tomography (OCT) are 
powerful tools for optical analysis of tissues with complimentary strengths. OCT excels 
and visualizing tissue microstructure while RS can relay tissue biochemical composition. 
The strengths and limitations of RS and OCT complimentary, and thus their combination 
offers the potential to enhance both data sets. Previous implementations of RS-OCT have 
employed separate system backbones for OCT and RS. Here, we present the design and 
application of a common detector combined RS-OCT instrument for evaluating the 
morphological and biochemical differences in a rat model for oxygen induced 
retinopathy. Rat pups that have undergone a variable oxygen treatment are compared to 
rats raised in room air. Images and spectra collected at an age of 26 days postnatal 
demonstrate differences in the thickness of the inner and outer nuclear layers, with OCT  
as well differences in the Raman spectral bands attributed to DNA and RNA nucleotides, 
amino acids, and proteins. 
 
Introduction 
Near-Infrared Raman spectroscopy (RS) is a powerful optical technique capable 
of detecting subtle biochemical differences between tissues. The spectral shift undergone 
by in-elastically scattered photons carries information related to the vibrational bond 
structure of the molecules within the sample. This high level of specificity is basis for 
which RS has demonstrated the ability to detect cancerous and pre-cancerous tissues1 and 
analyze the chemical composition of arterial plaques2. Despite the strength of RS for 
molecular characterization, the inherently week nature of in-elastic scattering limits the 
ability to relay information of tissue structure in a reasonable timeframe.  
In order to augment the biochemical sensitivity of RS with information related to 
tissue morphology, instruments combing confocal reflectance microscopy (CRM)3, wide-
field tri-modal imaging (WTM)4, and optical coherence tomography (OCT)5, 6 with RS 
have all recently been reported. The ability of the RS-CRM device to visualize cellular 
morphology can be invaluable for disease diagnosis; however the fine detail comes at the 
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expense of penetration depth and field of view. The RS-WTM instrument demonstrates 
how wide field multi-modal imaging can improve the spatial precision with which Raman 
spectra are acquired. While the imaging technique selected for each device is certainly 
motivated by the intended application, optical coherence tomography (OCT) can be 
considered advantageous due to its ability to perform high speed, wide-field of view 
imaging with micron scale resolution. As a result, two instruments combining RS and 
OCT have recently been reported to date. The first is demonstrated in highly scattering 
tissues such as the breast and skin, and performs RS at 785 nm and OCT at 1310 nm with 
a time-domain detection scheme5. The second performs RS at 633 nm and OCT at 855 
nm using spectral domain detection6 to evaluate the retina. Both systems are implemented 
using independent RS and OCT system backbones while being integrated at the sample 
arm. Dual-modal combined RS-OCT instrumentation can be further simplified, however, 
because both methods are capable of utilizing a spectrograph and CCD in their respective 
detection arms7, 8. Until recently, the speed and noise performance of CCD detectors was 
insufficient to perform high sensitivity detection of the OCT interference signal in the 
spectral domain9. If designed appropriately, however, it could be possible to realize an 
RS-OCT system using a common spectrograph and camera for detection. 
Non-invasive analysis of the retina is the most prominent application of OCT in 
clinical practice. The ability to clearly visualize retinal structure has allowed clinicians to 
better assess the pathological progression of diseases such as age –related macular 
degeneration, characterize structural defects such as macular holes, and improve 
treatment outcomes with early disease detection10. Recently, the utility of OCT as 
research using rodent models of retinal pathology has been explored, and found to serve 
as a useful biomarker for tumor progression in a rat model of retinoblastoma11 and retinal 
degeneration in a transgenic mouse model12. Such work would be well complimented by 
Raman studies, which are capable of identifying the molecular progression of disease. 
For example, recent work has demonstrated the sensitivity of RS to advanced glycation 
endproducts, molecules that are widely believed to play an important role in the ill-
defined pathogenesis of age-related macular degeneration13. Thus, the development of a 
combined RS-OCT instrument holds the potential to provide the unique tool for the 
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assessment of both the biochemical characteristics of retinal disease and the retinal 
structure with a single instrument. 
 
Materials and Methods 
Here, we present a combined RS-OCT system utilizing a common detector and 
demonstrate a potential application in evaluating the rodent retina. NIR Raman 
spectroscopy requires high sensitivity detection due to the inherently weak nature of 
Raman scattering. Cooled, back illuminated, deep-depletion CCD arrays with 
exceptionally low noise performance are necessary, along with spectrometers 
incorporating high throughput optics, and efficient gratings. This detection configuration 
can be adapted to perform spectral domain detection of the OCT signal, given the 
appropriate selection of the Raman and OCT sources and spectrograph dispersion. 
Fig 4.1a depicts the illumination of the detector. A wavelength stabilized external 
cavity 785 nm diode laser (Sacher) was selected as the Raman source because the 
resulting biological fingerprint band of 815 – 930 nm (500–2000 cm-1) best overlaps the 
range where OCT sources are available, along with the ready availability of high quality 
optics and filters for Raman detection. The selected OCT source (Exalos) is centered at 
850 nm with a 3-dB bandwidth of 40 nm and a full spectral width ranging from 
approximately 800-900 nm. An f/1.8 imaging spectrograph with a 785 nm Raman 
holographic transmission grating (Kaiser Optical Systems) is paired with a back 
illuminated, deep-depletion, thermo-electrically cooled 1024x256 CCD camera (Andor 
Technology, full well capacity = 186,000 e-/pixel) to perform detection of both signals. 
The spectrograph is configured to cover the wavelength range of 780 – 920 nm, which 
spans the full bandwidth of the OCT source and also largely covers the Raman fingerprint 
region. Separate 100 µm multimode and 6 µm single fibers couple the Raman and OCT 
signals, respectively, to the spectrometer. The spectral resolution is 0.123 nm for OCT, 
and 7 cm-1 for Raman. The resulting unaliased depth range of each OCT line-scan is 1.27 
mm, which is sufficient for imaging the rodent retina. Calibration of the spectrograph is 
performed with the atomic emission lines of a Neon-Argon lamp. 
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Fig.  4.1 (a) Illustrates the overlap between the Raman spectrum and the OCT source bandwidth 
along with a 2D image of the CCD illumination. (b) Overall RS-SDOCT System Schematic. PC – 
Polarization Control paddles, ND – Neutral Density filter, WC – Water filled Cuvette, TM – Translatable 
Mirror, LP – Long Pass filter, DM – Dichroic Mirror, BP – Band Pass filter, SF – Spatial Filter, XY – XY 
galvanometer pair, MOS – MEMS Optical Switch, NI-DAQ – National Instruments Multifunction DAQ. 
 
The overall system schematic is shown in figure 4.1b. The OCT source is coupled 
to a 50/50 fiber splitter, which directs light to the sample and reference arms. Polarization 
control paddles are placed in the source, reference, and sample arms to fine tune the 
splitting ratio and optimize the detected interference signal. The sample arm includes an 
XY galvanometer pair and a set of achromats which produce a 14 µW collimated 2.1 mm 
beam that the eye then focuses onto the retina. This configuration results in a fan shaped 
scan pattern that allows maximum retinal coverage when the pupil of the scan is placed 
near the pupil of the eye. The reference arm consists of a set of achromats,  a neutral 
density filter, and a 5 mm water filled cuvette. Insertion of the neutral density filter 
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allows the appropriate level of reference attenuation to optimize imaging sensitivity9. The 
optimized sensitivity of the system is measured at -86 dB. Care was taken to minimize 
degradation of the axial resolution due to dispersion mismatch.  The dispersion from the 
physical optics of the system was compensated for by placing matching achromats in the 
reference and sample arms, resulting in a measured axial resolution of 11 µm in air (8 µm 
in tissue). The water filled cuvette compensated for dispersion arising from the eye itself. 
An optical MEMS switch (Thorlabs) is placed in the detection leg of the fiber 
interferometer. During acquisition of OCT images, the interference signal passes through 
to the spectrograph. During Raman acquisition, however, the OCT signal returning from 
the reference arm is directed away from the spectrograph so as not to overwhelm the 
Raman scatter.  
The Raman illumination consists of free space optics integrated into the OCT 
sample arm. The multi-mode shaped source passes through a spatial filter and a 785 nm 
bandpass filter to produce a spectrally and spatially clean, collimated beam. A Raman 
dichroic mirror (Chroma) allows the beam to be co-aligned with the OCT beam and 
directed towards the sample. As with the OCT sample beam, the achromatic pair 
produces a collimated input beam with a power of 100 mW and a measured diameter of 
2.4 mm (after the final achromat) that is then focused onto the retina by the eye. The 
Raman scattered light then returns back through the sampling optics and dichroic, and is 
redirected towards the Raman collection fiber by a mirror mounted to a translation stage. 
Before fiber coupling an 818 nm long pass filter further rejects elastic scatter. During 
OCT imaging, the translation stage is shifted aside to allow the OCT beam to freely pass.  
The entire system is run off a single notebook computer with a LABView 
software interface. A multi-function DAQ device (National Instruments) allows software 
control of the optical MEMS switch, the translation stage mounted mirror in the sample 
arm, and the XY galvanometer pair. The instrument operates in either Raman or OCT 
mode. During OCT mode, the XY mirrors scan the beam across the retina to produce 
images while Raman scattered light is not detected. In Raman mode, OCT imaging is 
disabled and Raman spectra can be acquired from any XY galvo position, which 
correspond to the various depth scan axes of the previous OCT images and also noted in 
the OCT image display. 
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Data processing to produce OCT images and Raman spectra is performed in real-
time. To create and OCT image, the reference arm signal is stored before each image 
acquisition, and then subtracted from subsequent depth scans to remove the DC 
component of the interference signal. After DC subtraction, the spectrum is inflated and 
remapped from wavelength space to linear k-space14. Fast Fourier transform then 
produces the depth scan. Multiple OCT images can be further averaged to improve signal 
to noise ratio of the system. Only the bottom rows of the CCD that are exposed to the 
OCT illumination are binned in order to acquire OCT spectra at a maximum line rate of 
2.1 kHz. After factoring in data transfer and processing time, the frame rate of processed 
OCT images (512x512) is 2 frames/sec.  
In order to process the Raman spectra, a number of calibrations are performed 
prior to sample analysis. Variations in system throughput are corrected for using a NIST 
calibrated quartz-tungsten-halogen white-light lamp. Relative wavenumber calibration is 
performed with conventional Raman standards such as acetaminophen and naphthalene. 
Laser induced fluorescence from the system optics and general background light is 
removed by subtracting background spectra. After a sample spectrum is white light 
corrected and background subtracted, the tissue autofluorescence is removed using a 
modified polynomial fitting algorithm15.  
Images and spectra were collected from a rodent model for retinopathy of 
prematurity (ROP), ex vivo to demonstrate the capabilities of the common detector RS-
OCT instrument. ROP is generally considered a two-stage process arising from the 
variable oxygen tension preterm infants experience as a result of the therapeutic 
administration of supplemental oxygen and it’s subsequent removal. The initial hyperoxia 
inhibits normal development of retinal vasculature, however upon return to norm-oxic 
conditions, hypoxia in the underperfused peripheral retina can prompt the sudden 
development of irregular vasculature and the subsequent retinal pathology. In the rodent 
model, rats are exposed to variable-oxygen (VO) environments that alternate between 
hyperoxic and normoxic conditions that simulate the exposure preterm infants are 
subjected to after birth16. Here, litters of Sprague-Dawley rats were randomly separated 
into groups placed in either VO or room air (RA) environments. The VO rats were placed 
with mothers in infant incubators within 4 hours of birth. The rats were cycled between 
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alternating periods of 24 hours at 50% oxygen followed by 24 hours at 10% oxygen, for 
14 days. After the 14-day oxygen treatment protocol, the VO rats were moved to room air 
where 2nd stage of the pathological progression begins. Twelve days after removal from 
VO, denoted 14(12), distinct differences in the retina and retinal vasculature of the VO 
and age matched RA rats (denoted P26) are reduced, but still persist17. At this point, the 
rats were sacrificed, and the eyes were enucleated and placed in a small vessel atop a 
heating pad and half-submerged with phosphate buffered saline (PBS) (pH = 7.4, T = 
35˚). The vessel was placed on a heating pad in order to maintain the temperate. The PBS 
bath and heating pad were fixed to 3-axis translation stage that allowed the sample to be 
appropriately positioned under the sampling optics for analysis with RS-OCT. PBS was 
also dripped over the eye periodically to prevent dehydration of the cornea. All OCT 
images and Raman spectra were acquired within 30 minutes of death. All experiments 
were conducted in the Vanderbilt University Biomedical Optics Laboratory with 
protocols approved by the Institutional Animal Care and Use Committee at Vanderbilt 
University and carried out in accordance with the National Institute of Health Guide for 
the Care and Use of Laboratory Animals (NIH Publications No. 80-23) revised 1996. 
 
Results 
The eyes from five 14(12) rats and four P26 were evaluated to demonstrated the 
morphological and biochemical differences detectable with common detector RS-OCT. 
Figure 4.2 shows representative OCT from the 14(12) and P26 rat eyes, along with the 
corresponding histology sections. OCT images for analysis were generated by averaging 
20 successive frames. The images demonstrate the sufficient resolution and imaging 
range of the system to depict the retina. The clearest, most consistently visible layers 
include the hyper-reflective inner plexiform layer (IPL), a predominantly hypo-reflective 
band consisting of the inner nuclear layer (INL), outer plexiform layer (OPL), and outer 
nuclear layer (ONL), and outermost hyper-reflective regions of the eye which include the 
photoreceptor layers (PR) and choroid (C). Although less clear and consistent across the 
images, closer examination reveals the thin, hyper-reflective layer that corresponds to the 
nerve fiber layer at the innermost surface of the retina (NFL) proximal to a hypo-
reflective band corresponding to the ganglion cell layer (GCL). Between the inner and 
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outer nuclear layers, a thin hyper-reflective band can be made out that corresponds to the 
OPL. 
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Fig.  4.2 Representative OCT and histology of VO 14(12) vs. RA P26 eyes. Images depict the ability of 
RS-OCT to resolve retinal structure in both the VO and RA rats. The layers of the retina visible, from inner 
layers to outer layers, include the thin, bright nerve fiber layer (NFL), hypo-reflective ganglion cell layer 
(GCL), thicker hyper-reflective inner plexiform layer (IPL), the hypo-reflective inner nuclear layer (INL), 
the thin, bright outer plexiform layer (OPL), the hypo-reflective outer nuclear layer (ONL), and the 
photoreceptor layer and choroid (PR & C), which are difficult to distinguish. In the representative histology 
section (20x magnification), the choroid has detached from the retina due to processing artifact and can be 
seen below the photoreceptor layers. 
 
Although the images of the VO and RA retinas appear generally similar, the 
thickness of the hypo-reflective band consisting primarily of the nuclear layers (NL) of 
the retina (INL, OPL, and ONL) was measured to determine if any physical differences 
could be determined by RS-OCT. The NL band was selected because it is clearly defined 
across all the OCT images by the bright boundaries provided by the bottom of the IPL 
and the top of the PR layer. Figure 4.3a demonstrates how measurements of the layers 
were made. For each OCT image, a user defines 10 points along both the top and bottom 
boundaries of the NL. A 4th order polynomial is then fit to the points to define the 
boundaries. The algorithm calculates the length of a vector that runs from the top of the 
PR layer to the bottom of the IPL, orthogonal to the surface of the PR layer, for 100 
points evenly distributed across the retina. Thickness measurements were made on n=9 
eyes from the VO 14(12) group and n=8 eyes from the RA P26 group. Images were not 
collected from one of the 14(12) eyes because temperature and corneal hydration 
conditions could not be maintained well enough to allow transmission of the light 
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through to the retina.  The average NL thickness of the VO 14(12) group was 119 + 9 
µm, compared to 154 + 15 µm for the RA P26 group (fig. 4.3b). 
 
Fig.  4.3 Nuclear Layer Thickness Measurements in VO 14(12) vs. RA P26 retinas. (a)Thickness 
measurements of the hypo-reflective band that includes the INL, OPL, and ONL were made using an 
algorithm that fits a 4th order polynomial to user defined points along the upper and lower boundaries of the 
layers, and then calculates the mean distance between the fits. (b) Average thickness measurements of the 
VO 14(12) (n=9) vs. RA P26 (n=8) retinas. RA P26 thickness was greater (p < 0.0001). 
 
Following imaging, Raman spectra were acquired (tacquisition= 90 sec) from 9 
positions evenly distributed across the surface of the retina for each eye. Spectra were 
collected from the 9 viable eyes from the 14(12) group (n=77 spectra) and the 7 viable 
eyes from the P26 group (n=56 spectra). The mean spectra from the two groups are 
shown in figure 4.4, along with reference spectra of dissected retina and lens from adult 
Sprague-Dawley rats. Individual spectra with either prohibitively low signal-to-noise or 
cosmic rays overlapping tissue Raman features were excluded from analysis. Low SNR 
was defined as the ratio of the 1003 cm-1 peak divided by the standard deviation of a 
region that lacked strong Raman intensity from 779 to 814 cm-1 being less than 7. The 
spectral features of the VO and RA retinas generally show similarities to those from the 
reference spectra, as well as those reported in the literature18, 19. The spectra show Raman 
peaks at  1003 cm-1 (phenylalanine), 1265 cm-1 (amide III), 1440 cm-1 (CHx), 1660 cm-1 
(amide I) that are typical to most tissues because of their common occurrence in 
biomolecules. This is evident when comparing the spectra measured from the intact VO 
and RA eyes with the reference retina and lens spectra. 
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Fig.  4.4 Mean Raman Spectra of VO and RA retinas. The average spectrum of VO 14(12) (blue) and 
RA P26 (red) measured from intact eyes with RS-OCT. Reference spectra from dissected adult rat 
retina (purple) and lens (black) are also shown.  Spectral features visible in the VO and RA spectra 
attributable to both retina (i.e. 723, 1094, 1265 cm-1, highlighted) and the lens visible (i.e. 1549 
and 1611 cm-1). 
 
The retina is unique in that it consists primarily of neuronal cells and their 
synapses. Protein signatures present in Raman spectra include those arising from DNA 
and RNA molecules present in the nuclear layers, the most intense of which occur at 723, 
1094 cm-1. Although these features are visible in the spectra collected from the intact eye, 
there are also features that indicate a contribution from the lens, which is not unlikely due 
to the strong Raman scattering intensity of the lens. The relative intensity of the 1003 cm-
1
 phenylalanine peak, the 1549 and 1611 cm-1 aromatic protein peaks, and the position 
and shape of the amide III peak near 1230 cm-1 are characteristic of β-sheet proteins1, 
which exist in abundance in the lens. The amide III peak in α-helix proteins, which 
predominate in the layers of the retina, is normally shifted towards 1265 cm-1,18 as seen in 
the reference retina spectrum. In order to reduce the relative contribution of lens signature 
in our measurements, a scaled subtraction of the reference lens spectrum from the 
measured spectra was performed. The resulting mean spectra from the VO and RA 
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retinas are shown in figure 4.5. The spectral features are now much more characteristic of 
the retina. The relative intensity of the 1003 cm-1 peak is more in line with that measured 
and reported in the literature, and the amide III peak is more distinctly appears at 1265 
cm-1, characteristic of α-helix proteins constituent in the retina.  
Examination of the differences between the VO and RA lens subtracted retina 
spectra show a number of bands where differences reside.  RA spectral intensity is 
increased at the 723, 1094, and 1580 cm-1 peaks, which are attributed to DNA and RNA 
nucleotide groups1. Increased intensity also is seen in the band from 610 to 670 cm-1 as 
well as the peak at 754 cm-1, which have been attributed to amino acids and proteins1.The 
VO spectra exhibit differences in the peaks at 929 cm-1, a C-C peak commonly attributed 
to protein backbones, and a 965 cm-1 peak attributed to collagen molecules. In addition, 
the triplet of peaks in the band from 1315 to 1385 cm-1 shows increased intensity, which 
has been attributed to cytochrome-c content in the retina18.  
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Fig.  4.5 Mean VO and RA spectra after scaled subtraction of lens features. Differences are seen in 
peaks attributable to proteins and amino acids (610-670 cm-1, 754 cm-1, and 929 cm-1), DNA (723, 1094, 
and 1580 cm-1), collagen (965 cm-1) and cytochrome-c (1315-1385 cm-1). 
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Discussion 
The common detector RS-OCT instrument was able to both image and collect 
spectra from the retina. The OCT images depict the structure of the major layers of the 
retina typically seen in OCT images, while Raman spectra can be collected from the 
intact eye and processed to isolate signal primarily originating from the retina. The 50/10 
VO rodent model for ROP is a well developed model primarily utilized to evaluate 
pathological development of neovasculature.  After the rat pups are reintroduced to room 
air at 14(0), a strong vascular response is develops and peaks at 14(6), however by 14(12) 
the pathological vasculature has largely resolved. Although the speed of the vascular 
regression is one criticism of the model, as a whole pathological features have been 
shown to persist17. A developmental delay is very likely to result from the irregular 
retinal perfusion from 14(0) to 14(12), and our results seem to indicate that measures of 
this can be made with RS-OCT. Taken together, the Raman signatures provide 
information that both builds upon the morphological information seen in the OCT, as 
well as compliments it. The increased intensity of the DNA and amino acid peaks seems 
in line with the increased nuclear layer thickness measured by OCT. In humans, 
advanced ROP can be severe enough to result in retinal detachment with extreme 
irregularity in vasculature growth patterns or significant increase vascular permeability. 
In the animals examined here, the speed with which the pathological vasculature re-
normalized seem to prevent any detectable detachments with OCT. The inability of the 
OCT images shown here to clearly distinguish between the photoreceptor layers, retinal 
pigment epithelium, and choroid likely would have made this task quite difficult in the 
case of minor detachments.  
Spectral changes that do reflect features of in the OCT image can be particularly 
interesting. The spectral changes observed in the 1315 to 1385 cm-1 range imply 
biochemical differences that between the VO and RA retinas that are not clearly reflected 
in OCT. A similar triplet of peaks was seen in work utilizing confocal RS to collect 
spectra from the mitochondria rich photoreceptor inner segments and attributed to 
cytochrome-c18, a protein localized in the mitochondria associated with cellular 
metabolism. In the retina, mitochondria are localized in the photoreceptor layer, where 
production and turnover of the membrane bound visual pigments takes place. One 
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possible explanation of the increased cytochrome-c content in the VO rats may be an 
increased level of rhodopsin generation in the developmentally delayed animals. The 
collagen feature arising from the 965 cm-1 peak may be attributable to collagen fibrils at 
the vitreo-retinal interface, which are believed to play a role in vitreal traction20. In the 
case of the VO rats, a significant portion of the pathological retinal vasculature develops 
as tufts into the vitreous. A hypothesis for increased collagen features may be related to 
their necessity to maintain vitreal traction in the VO rats.  The increased spectral intensity 
associated with C-C backbone at 929 cm-1 is more difficult to attribute without further 
analysis due to its widespread presence among bio-molecules. Although no clear 
conclusions can be drawn at this stage from any of the biochemical differences seen in 
the Raman spectra, it is clear that they provide unique information that can be expanded 
upon to better understand the molecular differences between the retinas of VO 14(12) and 
RA P26 animals.  
Appropriate design of the common-detector RS-OCT instrument required the 
appropriate selection of light sources suited to the tissue of interest as well as facilitate a 
common detector. Typically, NIR Raman is performed with sources between 633 - 
830nm and Silicon-based detectors. As the excitation wavelength is increased, scattering 
intensity and detector responsivity fall off, while background tissue autofluorescence 
tends to decrease. An additional critical factor is the availability of the appropriate filters 
to reject elastic scatter and attenuate laser background. For OCT imaging, broadband 
sources with bandwidths amenable to micron scale resolution are typically found at the 
optical communication bands between 800 to 850 nm, 1310 nm, and 1550 nm. OCT 
source selection is typically a function of the target tissue of interest. In highly scattering 
tissues such as the GI tract and skin, longer wavelengths are preferred due to the lower 
scattering coefficients of tissue facilitating deeper penetration. Imaging the retina, 
however, requires the light pass through the aqueous and vitreous to arrive at the retina, 
and thus OCT sources from 800 to 850 nm are preferred due to their proximity to minima 
in the water absorption spectra. Ultimately, the selection of a 785 nm source for Raman 
and 850 nm source for OCT allowed both the appropriate overlap for common detection 
as well as the optimal wavelengths for retinal analysis. 
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The performance characteristics that result from the spectrometer design are 
critical in both RS and OCT, however their requirements are not necessarily the same. 
The appropriate range of spectral coverage for detection of the biological molecules lies 
in the organic fingerprint region of 500 to 2000 cm-1 relative wavenumbers, with spectral 
resolutions of at least 10 cm-1 to detect the sharp features of the Raman signature. In 
spectral domain OCT, the axial resolution is inversely related to the laser source 
bandwidth while the maximum un-aliased depth range is inversely related to the spectral 
resolution. Therefore, a detection system designed with too narrow a spectral range will 
degrade the axial resolution, while a detection system with too large a spectral range can 
degrade the spectral resolution and result in an unaliased depth range less than the optical 
penetration depth in tissue. The ultimate design of the spectrograph allowed a sufficient 
spectral resolution for both a sufficient un-aliased OCT imaging depth and resolution of 
the sharp features of tissue Raman spectra, along with sufficient spectral coverage to 
include the tissue “fingerprint” region as well as achieve the full axial resolution in OCT. 
The OCT resolution allows visualization of the retinal layers in the rodent model, 
however the overall speed and sensitivity of the instrument are sacrificed at the expense 
of Raman sensitivity.  The maximum achievable readout rate for high-sensitivity CCD’s 
is purposefully low in order to minimize the noise associated with higher bandwidth 
amplifier electronics. Similarly, CCD full well capacity is typically kept at a minimum in 
order to optimize dark noise performance for the benefit of RS. In OCT, a higher full well 
capacity is necessary in order to detect large reference DC signal required to generate 
interference. An increased well capacity would prevent camera saturation at such low 
power levels, and allow more power delivered to the sample. OCT performance could be 
slightly improved through selection of a CCD with faster electronics and larger wells, 
however it would come at the expense of RS quality. Despite the fact that the detection is 
optimized for Raman sensitivity, the high illumination power and long integration times 
necessary for RS remain the limitations of the instrument. These parameters would surely 
need to be reduced for any human application; however they do not preclude feasibility in 
rodent models.  
In conclusion, we have demonstrated the feasibility of a common detector 
combined RS-OCT instrument for the ex vivo characterization of the morphological and 
 72 
biochemical features of rodent retina. The ability of the instrument to sequentially acquire 
high resolution images and high quality Raman spectra was demonstrated in a rodent 
model for ROP. Combined RS-OCT was successful in identifying changes in both of the 
thickness and biochemistry of the pathological retinas. Future work consists of 
demonstrating the feasibility of the instrument for characterizing rodent models for 
retinal pathology in vivo. 
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Abstract 
Skin cancer is the most commonly occurring cancer, with incidence rates rising annually. 
Realizing favorable outcomes requires early diagnosis, for which the current standard is 
biopsy followed by histopathology. This process can be invasive, subjective, time 
consuming, and costly. Optical techniques, including Optical Coherence Tomography 
(OCT) and Raman Spectroscopy (RS), have been developed to perform non-invasive 
characterization of skin lesions, however neither is without limitation. Here, we 
demonstrate a clinical instrument for morphological and biochemical characterization of 
skin cancers with combined RS-OCT. The portable instrument utilizes independent RS 
and OCT system backbones, and is integrated in a common clinical probe. The potential 
of the probe for cancer diagnosis is demonstrated on malignant and non-malignant 
lesions. 
Introduction 
Skin cancer is the most commonly occurring of all cancers, accounting for more than 
a 1.7 million incidences in the United States annually1. In addition, the incidence rates for 
skin cancer are growing, particularly among young Caucasian women aged 15-34 (3.8% 
annually) and Caucasian men aged over 65 (8.8% annually) 1. The two most common 
types of skin cancer, basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), 
are highly curable if detected at an early stage.  The most dangerous skin cancer, 
malignant melanoma, can have a 5 year survival rate of only 16% at it’s most advanced 
stage, cases detected in situ have survival rates of 99%2. Early diagnosis and thorough 
treatment (i.e., complete resection) are the keys to gaining a favorable prognosis; 
however diagnosis of skin cancers can be difficult. Many benign lesions visually 
resemble malignancies, and in elderly patients with a large number of irregular skin 
lesions, it can be easy to overlook disease. While in many cases, preemptive removal may 
be a simple solution, it can result in unnecessary cost and patient discomfort. Reliable 
clinical diagnosis typically requires biopsy and subsequent histo-pathological 
examination. Clinicians are then presented with the challenge of deciding which and how 
many skin lesions to biopsy, usually relying on visual inspection and palpation. This 
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protocol for skin lesion diagnosis is accepted as the gold-standard; however it can be 
subjective, invasive, time-consuming, and costly. These limitations motivate the 
development of non-invasive techniques capable of direct characterization and 
monitoring of potentially cancerous skin lesions. Such tools have the potential to assist in 
biopsy guidance, or possibly even circumvent the need for histology.  
Optical techniques have demonstrated the potential to perform non-invasive 
characterization of skin cancers. Imaging techniques such as confocal microscopy3 and 
optical coherence tomography (OCT)4 are advantageous because they allow non-invasive  
visualization of tissue micro-structure similar to that currently obtained invasively with 
histology. However these techniques are typically limited in their ability to characterize 
the tissues biochemical composition, and therefore lack the specificity necessary for 
disease classification. Spectroscopic techniques including fluorescence5 and Raman 
spectroscopy (RS)6, have been demonstrated capable of performing highly specific 
disease classification with automated, statistical algorithms that provide objective 
correlation of spectra to pathological state. Unfortunately, these spectroscopic techniques 
typically lack the ability to perform imaging at high resolutions in clinically relevant 
timeframes. 
The appropriate combination of imaging and spectroscopy methods can take 
advantage of the complimentary nature of the data sets structural and biochemical 
sensitivity to result in a clinical device that provides more complete information for 
diagnosis and tracking of skin cancers. The development of multimodal instruments 
combining imaging and spectroscopy is the most straightforward approach to realize 
these potential benefits. For instance, combined laser induced fluorescence-OCT 
demonstrated the advantages of combining imaging with spectroscopy to characterize the 
cancer in the colon of a rodent model7. In the skin, a confocal RS-confocal reflectance 
microscopy probe demonstrated the ability to acquire images with cellular level 
resolution along with the micron scale biochemical analyses of tissue structures,  in vivo8. 
For the specific purpose of clinical screening and diagnosis of skin cancer, however, such 
approaches are limited.  
Although confocal reflectance microscopy can achieve excellent resolution, the 
limited imaging depth can prevent accurate determination of the depth of tumor cell 
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invasion for staging, while the limited transverse field of view (FOV) can restrict the area 
of skin that is observable in a single clinical session. OCT, on the other hand, is able of 
achieving micron-scale resolution with extended penetration depths and over a larger 
FOV, which simplifies clinical application. While common implementations of OCT do 
not achieve sub-cellular resolution, the technique has still been demonstrated capable of 
visualizing the microstructural features of a wide range of skin cancers9, 10.  In addition, a 
recent study demonstrated that dermatologists and pathologists could be trained to 
identify skin lesions such as BCC and actinic keratosis (AK, a non-malignant skin lesion) 
with a sensitivity of as high as 96%, indicating that OCT provides an excellent tool for 
detecting disease11. However, these observers had a difficult time determining if the 
lesion was a BCC or an AK, indicating the limitation of OCT to perform classification 
based on strictly tissue morphology.  
Conversely, RS would seem to be an excellent spectroscopic approach for highly 
specific classification of disease type.  In comparison to autofluorescence spectroscopy, 
which is sensitive to a limited number of intrinsic fluorophores in the skin, Raman 
spectroscopy is sensitive to a wide number of molecular moieties in the skin12. In a direct 
comparison with autofluorescence and diffuse reflectance spectroscopy, Raman 
spectroscopy has been shown to achieve superior classification performance in the 
context of breast cancer diagnosis.  In the skin, Raman spectroscopy has demonstrated 
the ability to perform direct multi-class classification of skin diseases with overall 
accuracies of 95% 6, 13. The combination of RS and OCT would facilitate high-resolution 
imaging of the microstructural features of skin disease, along with highly specific 
characterization of the biochemical composition of skin cancers.  The potential 
advantages of combined RS-OCT have previously been reported in a non-portable 
benchtop configuration14. Here, we describe the design and application of a clinical 
instrument for combined RS-OCT for in vivo imaging and spectroscopy of skin cancers.  
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Materials and Methods 
System Instrumentation 
The combined RS-OCT system schematic is shown in figure 5.1a. The backbone of 
the OCT subsystem is a typical high-speed time-domain configuration. A 1310 nm fiber 
coupled optical amplifier source (∆λFWHM = 60 nm, AFC technologies) is coupled to a 
2x2 fiber splitter (50:50 coupling ratio). The reference arm consists of a rapid scanning 
optical delay line that facilitates high speed imaging up to 32 frames/second (data 
collected here was acquired at 2 frames/second) 15. The OCT subsystem is fiber coupled 
to a custom designed RS-OCT probe that directs the light onto the sample. The light 
returning from the sample probe interferes with the light returning from the sample arm at 
the fibersplitter. The interference signal is then detected by a balanced detector that 
collects the interference signal in the detection leg as well as the interference signal 
circulated back from the source arm for high sensitivity detection (-105 dB) 16.  The 
electronic signal is then band pass filtered and detected with a multi-function analog 
input / analog output data acquisition device (National Instruments). The Raman 
subsystem consists of a wavelength stabilized laser diode source located entirely within 
the probe and controlled externally by an electronic module (Innovative Photonics 
Solutions, Inc.). The Raman scatter is collected, fiber coupled, and sent to a high 
throughput spectrograph (Kaiser Optical Systems) that disperses the light onto back 
illuminated, deep depletion, thermo-electrically cooled CCD (Andor Technologies) for 
detection. All the components of the OCT and RS subsystems are housed with in a 
mobile cart (fig 5.1b) that facilitates transportation to the clinic, and mobility from one 
exam room to another. 
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Fig.  5.1 RS-OCT System: Schematic diagram of the clinical RS-OCT system (a). The OCT subsystem 
consists of a 1310 nm source coupled into a 50/50 fiber splitter. Reference Arm consists of a rapid scanning 
optical delay (RSOD). A circulator redirects light returning to the source towards a balanced detector (BD). 
The interference signal is then band-pass filtered (BPF), and detected with an analog input/output data 
acquisition card (AI/AO DAQ). The DAQ generates galvanometer control (GC) output signals, along with 
the line sync (LS) and frame sync (FS). The Raman subsystem consists of the laser source’s electronic 
control (EC) module that is tethered to the laser diode which resides within the body of the probe. The 
Raman scatter is fiber coupled in the probe and detected with a spectrograph and CCD.  A photograph of 
the RS-OCT system (b) shows the cart, mechanical arm, probe, and software interface layout. 
  
Combined RS-OCT Sample Probe 
The combined RS-OCT sample probe is depicted in figure 5.2. The Raman source is a 
785 nm diode laser device with a 1” x 1” footprint that contains the diode and TEC 
(Innovative Photonics Solutions). The source outputs a collimated beam that is band pass 
filtered and co-aligned with the OCT beam at dichroic mirror 1. The objective lens and 
galvanometer (Cambridge Technologies) are configured to generate a telecentric scan for 
OCT image generation. The measured axial resolution of OCT is 14 µm. The objective 
lens focuses the OCT beam to a 25 µm lateral spot (POCT sample = 7 mW). During Raman 
acquisition, galvanometer scanning is stopped, and the Raman spectrum is acquired from 
the central optical axis of the objective lens. The Raman beam is focused to a 44 µm 
lateral spot with a measured confocal parameter of 3.8 mm (PRaman sample = 50 mW). The 
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Raman scatter band from 800 - 950 nm is separated from the Raman excitation and OCT 
by dichroic mirror 2 (Chroma Technologies, Inc.), long pass filtered (Semrock, Inc. λcutoff 
= 808 nm) to further reject elastic scatter, and coupled into a 100 µm low-OH fiber for 
detection. The overall size of the probe is 4” (H) x 5”(W) x 8”(L).  The probe is mounted 
to a manually manipulated mechanical arm that supports the probe’s weight and provides 
stability during collection of Raman spectra (seen in fig 5.1b). The operator is still 
required to hold the probe in place during imaging and spectral acquisition. 
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Fig.  5.2 Schematic diagram of the clinical probe. The Raman laser diode (RLD) is band pass filtered 
(BP) and co-aligned with the OCT beam at dichroic mirror 1 (DC 1). The Raman excitation and OCT 
beams are directed at the sample via a galvanometer (G) and objective lens (OL) pair that perform a 
telecentric scan of the OCT beam during imaging. The Raman scatter is separated from the OCT and 
Raman excitation by dichroic mirror 2 (DC 2), long pass filtered (LP) and detected by the Raman collection 
(RC) optics. A foam pad (F) is attached to the sample end of the probe for patient comfort.   
 
Data Pre-processing and Software Interface 
A custom designed software interface (LabView) performs instrument control, data 
acquisition, data processing, and image / spectrum display for both the OCT and Raman 
systems. The software performs demodulation of full interferometric OCT signal, and 
real-time processing and display of both the OCT image and Raman spectra. 
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Calibration of the spectral dispersion of the Raman system was performed daily using 
the atomic emission lines of a neon-argon lamp prior to data collection. Variations in 
spectral throughput of the system were calibrated using a NIST-certified quartz-tungsten-
halogen lamp. Relative Raman wavenumber shift was calibrated with acetaminophen and 
naphthalene standards. Background spectra are acquired to remove laser-induced 
fluorescence from the sampling optics. Spectral pre-processing includes binning the data 
to ½ the spectral resolution and high frequency noise removal with a 2nd order Savitzky-
Golay filter with a window size twice the spectral resolution. Finally, background tissue 
autofluorescence was subtracted with a modified polynomial fitting algorithm17, and the 
resulting spectra were area normalized in order to maintain potentially relevant 
information from all peaks.  
 
Study Protocol 
The combined RS-OCT clinical system and probe were used to characterize skin 
cancers in the Dermatology service of the Veterans Affairs – Tennessee Valley Health 
Care System (VA-TVHS). All procedures were performed in accordance with a protocol 
approved by the VA-TVHS institutional review board.  
Patients presenting in the clinic for routine resection of lesions previously identified 
as cancerous via biopsy and pathology were eligible for enrollment. In some instances, 
the initial biopsy removed the entire lesion, resulting in a lesion that consisted simply of 
scar tissue, while in other cases significant tumor cells remained. OCT images of the 
presumed lesion were acquired to provide an overview of its microstructural features. 
OCT imaging was then suspended and Raman spectra were acquired from the center of 
the lesion for biochemical characterization. Due to the inherent heterogeneity of skin, 
spectra and images were then acquired from regions directly adjacent to the lesion that 
appeared visibly normal (within 3-4 cm’s) for comparison. Three (3) spectra from each 
measurement location were averaged to produce a single spectrum per position. The 
acquisition time for individual Raman spectral was 30 seconds. After data acquisition, a 2 
mm punch biopsy was taken from the center of the lesion near the Raman measurement 
site for histopathological correlation with the RS-OCT data. In addition, the results in 
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patient record from histopathology of the entire removed tissue area were also noted to 
confirm punch biopsy diagnosis. Lesion resection typically includes 1 cm clear margins. 
Results 
An OCT image of normal skin from the forearm of a 62 year old male is shown in 
figure 5.3a. The epidermal layer is non-distinct, but can be observed as a slightly darker 
band indicated by the black arrow on the far left of the image. The OCT image from the 
corresponding lesion is shown in figure 5.3b. The OCT image displays some clear 
morphological irregularities indicative of a lesion, however both the 2 mm punch biopsy 
(fig. 5.3d) and the pathology report in the patient record indicated that the entire area was 
clear of tumor. The red arrow in the OCT image frame approximates the position at 
which the lesion Raman spectra were acquired. The mean Raman spectra from the two 
positions are shown in figure 5.3c. The overall shapes of the spectra show subtle 
differences in intensity near 630 cm-1 and the band from 1250 to 1350 cm-1. 
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Fig.  5.3: RS-OCT of a forearm scar lesion. (a) OCT of normal skin adjacent to the lesion. Characteristic 
features include the lack of morphological irregularities and a relatively consistent attenuation of signal 
through the dermis. (b) OCT of scar. Red arrow approximates location of Raman acquisition. Dashed white 
lines outline approximate correlation with 2 mm punch biopsy (d). White arrow indicates landmark dip in 
skin surface. Raman spectra (c) are fairly similar. Scar contains higher content in band from 1250 to 1350 
cm-1  
 
Figure 5.4 depicts the RS-OCT data collected from an 83 year old male with a 
superficial BCC of the zygoma (cheekbone). The OCT image of the adjacent normal skin 
(fig. 5.4a) shows some signs of structural inconsistency in contrast with the normal skin 
seen in figure 5.3a. The dark protrusions nearly orthogonal to the surface of the skin may 
be hair follicles. The OCT of the superficial BCC also shows a number of signs of hypo-
reflective sub-dermal irregularities that may be either non-malignant features such as hair 
follicles and sebaceous glands, or tumor cell nests. The Raman spectra (fig. 5.4c) show 
distinctly different spectra from the lesion and adjacent normal skin. The most notable 
difference is in the lineshape and peak ratios of the features in the 1250 to 1350 cm-1 
band. In addition, the width of the 1666 cm-1 peak shoulder is broadened, as seen by 
increased intensity in the 1625 cm-1 wavenumber region.  The data from RS-OCT of a 
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BCC is shown in figure 5.4. Pathology confirmed diagnosis as a BCC, but was cut 
longitudinally, and therefore not shown. 
 
(a)
(b)
(c)
 
Fig.  5.4: RS-OCT of Basal Cell Carcinoma of Right Zygoma (cheekbone). OCT image of normal skin 
adjacent to lesion (a) shows some features of sub-surface irregularity that are likely hair follicles. The 
lesion OCT image shows a number of dermal irregularities with both thin and larger hypo-reflective 
scattering features. Red arrow approximates position where lesion Raman spectra were acquired. Distinct 
differences are seen in the Raman spectra (c) acquired from the BCC and normal, particularly in the 1250 
to 1350 cm-1 band and the region around 1625 cm-1 band. 
 
Discussion 
The OCT images of the normal skin (figs. 5.3a, 5.4a) demonstrate the 
characteristic appearance of normal skin. Normal skin on the forearm is quite different 
from normal skin on the face, which can be seen in the figures. The forearm skin shows 
fairly consistent signal decay as a function of depth and a general lack of absorptive or 
scattering irregularities that would result in hyper- or hypo- reflective features. In 
contrast, the image of normal skin on face contains some more irregularities indicative of 
tissue heterogeneity. The skin on the face is known to have higher concentrations of 
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sebaceous glands in comparison to other locations on the body. These structures typically 
surround hair follicles, and seem to appear as appear as dark, hypo-reflective features18. 
These features have a wide variety of shapes in histopathology, based on the angle of the 
cut, and therefore should also be heterogenic in the OCT cross sections. If they are 
imaged at the right angle, they should be visible emerging to the surface of the skin, as is 
likely the case with the features identified by the white arrows in figure 4a. The features 
of the skin on the face (fig. 5.4a, 5.4b) also exhibit characteristics indicative of shaving, 
including a flat surface and a more visible, flattened smooth epidermal layer.  
The Raman spectra acquired from both the lesions and their adjacent normal skin 
sites have features that are typical of the skin19, 20. These features include the 
tyrosine/protein peak near 850 cm-1, phenylalanine ring breathing peak at 1003 cm-1, the 
PO2 symmetric stretching peak attributed to lipids as well as the nucleic acid backbone in 
the 1070-1090 cm-1 band, the amide III band centered around 1304 cm-1, the 1440 CH2 
peak, and the 1660 cm-1 amide I are all clearly visible, in addition to other less prominent 
spectral features. 
In contrast to the image of the normal forearm skin, that of the forearm scar shows 
distinct morphological irregularities at both the surface and in the underlying dermis. The 
process of re-epithelialization of the wound’s has been observed with OCT21,  and this 
image contains the hallmarks of such a process. On the surface, the scar appears distinctly 
flat and smooth. The newly formed epithelial layer is more distinct, flat, and smooth,  
underneath which is the bright hypo-reflective scar tissue just to the left of the red arrow. 
The Raman spectra are fairly similar. Normal skin shows increased signal at 634 cm-1, 
while the scar/inflammation tissue shows an increased band from 1250 to 1350 cm-1. The 
spectral lineshape of the 1270, 1304, and 1348 cm-1 peaks suggests an increase nuclei and 
protein contribution comes22, and may indicate an increased presence of inflammatory 
cells in the involved area. 
The superficial BCC OCT image contains markedly more hypo-reflective 
structures in the underlying dermis in comparison to its normal counterpart, however it is 
difficult to assess much more than that due to the generally similar appearance of 
features. BCC tumor cell nests have been similarly reported to appear and dense hypo-
reflective regions in the tissue9, which is similar to sebaceous glands. The morphology of 
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both BCC and sebaceous glands cannot necessarily be predicted, and as such it is difficult 
to assess the features based on their shape. The Raman spectra, however, provide some 
indication of the biochemical composition of the tissue. The differences in the spectra 
seem to indicate higher lipid content in the normal skin compared to the cancer. This is 
based on the different spectral lineshape of 1250-1350 cm-1 amide III band, as well as the 
narrower width of the amide I band at 1667cm-1. The spectral lineshape of the 1270, 
1304, and 1348 cm-1 peaks suggests the contribution comes predominantly from lipids as 
opposed to proteins22. This may suggest that the hypo-reflective regions are primarily 
tumor cell nests as opposed to sebaceous glands.  
We have demonstrated a clinical system and probe for combined RS-OCT 
analysis of cancerous skin lesions, in vivo. The images and spectra reflect the wealth of 
additional information that available from both morphological and biochemical 
characterization of skin lesions with combined RS-OCT. It is clear, however, that the 
primary challenge now becomes interpreting the data sets, particularly in the context of a 
complex clinical problem such as skin cancer detection. The inherent variability in the 
structure of normal skin as a function of body location and gender are readily apparent in 
the OCT images. Obtaining meaningful information from these images will surely require 
extensive analysis of many lesions in order to generally understand the biological 
significance of hypo- or hyper- reflective structures and their morphological features. In 
addition, development and validation of a functional statistical classification algorithm to 
realize the full power of molecular analysis with spectroscopy will also require the 
collection of a large number of spectra. The analysis of these complimentary data sets is 
likely to improve the clinical utility of beyond that attainable through the use of both 
techniques independently. Added features to improve the clinical utility of the probe, 
including video imaging would benefit the clinical ease of implementation as well. 
Nevertheless, we have demonstrated the potential of combined RS-OCT for the diagnosis 
of skin cancers through the development of a clinical device capable of in vivo 
morphological and biochemical analysis. 
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CHAPTER VI 
CONCLUSIONS 
Summary 
 The goal of this dissertation was to develop the technique of combined Raman 
spectroscopy – Optical Coherence Tomography (RS-OCT) and construct a clinical 
system for the in vivo measurement of questionable skin lesions. Previous work in the 
field of Raman Spectroscopy (RS) for skin cancer diagnosis1, 2 had identified the potential 
benefit of combined high-resolution imaging with RS. In addition questions had arisen as 
to the necessity of a confocal collection geometry to accurately classify skin cancers in 
vivo.    
In order to address the necessity of confocal collection for in vivo classification of 
skin cancers with RS, the first aim of this work was to perform a pilot study to assess the 
ability of fiber optic probe based RS to classify skin cancers in vivo. Spectra of 34 lesions 
from cancerous and non-cancerous tissue, along with matched spectra from similar 
normal skin, were measured with fiber optic probe based RS. Difference (lesion – 
matched normal) spectra were calculated to account for inherent variations in the skin. 
Difference spectra were classified using Sparse Multinomial Logistic Regression 
(SMLR). Spectra were classified with an overall accuracy of 85%. The sensitivity and 
specificity were 78% and 94% respectively. These results suggest the potential utility of 
non-confocal RS for accurate classification of skin cancers, however a more extensive 
research is necessary. 
The second aim of this dissertation was to develop a benchtop combined RS-OCT 
system utilizing separate OCT and Raman system backbones. A dual-modal device 
capable of sequential acquisition of Raman Spectroscopy (RS) and optical coherence 
tomography (OCT) along a common optical axis was constructed. The system 
performance was characterized, and capability of the device to identify structurally 
ambiguous features within an OCT image with RS in a scattering phantom, guide 
acquisition of RS from a localized malignancy in ex vivo breast tissue, and perform in 
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vivo tissue analysis of a scab. The device enhances application of both RS and OCT by 
precisely guiding RS acquisition with OCT images while also compensating for the lack 
of molecular specificity in OCT with the biochemical specificity of RS. The results 
indicate the potential capability of RS-OCT for in-vivo morphological and biochemical 
analysis of the skin. This work was published in Optics Letters in 2008. 
The third aim of this dissertation was to develop a benchtop combined RS-OCT 
using a common detection arm. Previous implementations of RS-OCT have employed 
separate system backbones for OCT and RS. Here, we present the design and application 
of a common detector combined RS-OCT instrument for evaluating the morphological 
and biochemical differences in tissue. The instrument is applied to evaluating a rat model 
for oxygen induced retinopathy. Rat pups that have undergone a variable oxygen 
treatment are compared to rats raised in room air. Images and spectra collected at an age 
of 26 days postnatal demonstrate differences in the thickness of the inner and outer 
nuclear layers, with OCT  as well differences in the Raman spectral bands attributed to 
DNA and RNA nucleotides, amino acids, and proteins. The results from this study 
demonstrate the first implementation of common detector RS-OCT, however they 
suggest that the independent detection of the RS and OCT signals is the optimal approach 
for in vivo analysis of skin lesions.  
The final aim of this dissertation is to develop a clinical system for combined RS-
OCT for analysis of the morphological and biochemical features of skin cancer. The 
portable instrument utilizes independent RS and OCT system backbones, and is 
integrated in a common clinical probe. The potential of the probe for cancer the detection 
of the morphological and biochemical features of malignant and non-malignant lesions is 
demonstrated. The results from this aim indicate the potential of RS-OCT for evaluating 
skin cancers, and warrant more extensive work. 
 
Future Directions 
The work done is this dissertation has demonstrated the feasibility of combined 
RS-OCT in a clinical setting, and has laid the basic foundation for performing a full 
assessment of the performance of RS-OCT for skin cancer screening, diagnosis, and 
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staging. In order to make a proper assessment of this approach, however, more clinical 
work is necessary.  
Raman spectroscopy for skin cancer diagnosis 
The fiber-optic probe based clinical study should continue, and more patients 
ought to be enrolled. Although the classification performance achieved in the fiber optic 
probe study did not match that of previous in vivo confocal studies, the result can easily 
be attribute to sample size limitations. Previous in vivo work consisted of a study which 
enrolled just 21 patients, in comparison to the 34 used for the fiber probe study. Neither 
of these studies is sufficiently powered to draw any real conclusions as to the superiority 
of one technique over another. The best course of action for accurately determining the 
relative performance of the two collection geometries is to conduct side-by-side analysis 
of fiber-probe based RS with confocal RS on the same lesions, with the probes both 
placed over identical spots within the lesion. Obviously, the appropriate sample size 
estimation needs to be made based on the study design and statistical classification 
algorithm pursued. Ultimately, this number will likely be quite large, because simple 
two-class differentiation of cancer from normal is only the intermediate goal. The 
biochemical specificity of Raman suggests, and has been demonstrated capable of, direct 
multi-class differentiation of skin cancers3. The long term goal of RS in the skin should 
be directed towards multi-class differentiation of normal skin, the set of benign skin 
lesions that commonly mistaken for skin cancer, BCC, SCC, and melanoma.  
Subsequent to the development of SMLR, a few alternative statistical pattern 
recognition and machine learning algorithms have been proposed for classification of 
Raman spectra. These include the combination of maximum representation and 
discrimination feature in combination with SMLR (MRDF-SMLR)4 and Generalized 
Linear Models (glmnet)5. MRDF-SMLR performs a set of arbitrary non-linear operations 
on the input data to tease out higher order correlations in the data prior to applying SMLR 
machine learning for classification, however development of this algorithm requires a set 
of subjective, non-optimizable decisions be made as to the initial non-linear operations. 
This results in the generation of classification frameworks that are difficult to reproduce. 
In addition, the nature of the algorithm make it impossible to determine which spectral 
features are being relied upon for classification, which detracts from the potential 
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advantage of RS for specific biochemical characterization of the features of pathology. 
The machine learning framework of glmnet is currently being evaluated by our group in 
collaboration with the Vanderbilt Biostatistics department. The advantages of glmnet 
include a superior set of machine learning heuristics that promote easier generalization of 
the model and are less susceptible to over-learning the training data. Pursuing the 
appropriate application of these methods will be critical to realizing the full diagnostic 
potential of RS. 
Despite the fact that no clear statistical determination can be made as to the 
performance of the fiber optic probe for skin cancer classification, there are two reasons 
that suggest switching to a different probe design may be appropriate. Considering the 
fact that skin cancers present primarily in the dermis, a non beam-steered approach may 
be advantageous to biasing the collection more towards the underlying tissues and less 
towards the epidermis. The second, more pragmatic reason, is that the beam-steered 
probe used in this study is a proprietary technology from the now-defunct Visonex, Inc. , 
no longer available. Further effort to demonstrate the capability of this probe would serve 
limited practical purpose. A more suitable probe would simply have flat-polished 
collection fiber surrounding the illumination fiber. The collection geometry of such a 
probe would be less biased to surface tissues and have greater contributions from 
underlying regions.  
Combined RS-OCT 
 Aims #2 and #3 of this dissertation provided proof-of-principle demonstrations of 
the feasibility of RS-OCT with independent and common detection arms. Broadly, this 
work demonstrated the ability of RS-OCT to perform both morphological and 
biochemical analysis of tissues in the breast and retina (ex vivo), and the skin (in vivo). 
The advantage of the approach is that it overcomes the direct limitations of the lack of 
biochemical sensitivity in OCT and the lack of morphological information in RS.  
From the instrumentation perspective, the integration of RS and OCT is a 
challenge. The laser source requirements for the two systems are opposite; RS requires a 
narrow band, wavelength stabilized laser while OCT requires either a broadband source 
or a rapidly swept narrow band source. The relative intensity of elastic scattering (the 
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source of signal in OCT) vs. in-elastic scattering (the source of contrast in RS) affects 
both the source and detection parameters of both systems. In order to detect high quality 
signal from tissues, RS requires both a fairly high power at the sample (minimum 20 
mW) and extremely sensitive detection electronics, while OCT can make due with much 
lower powers (µW in the cast of SD-OCT) and less sensitive detection electronics. In this 
context, there is no middle ground for integration of either source or detection hardware. 
That suitable for RS must be utilized at the expense of OCT. Regardless, CCD detector 
technology continues to improve, and it is entirely possible that with redesign of the 
detectors to increase the potential speed (wider bandwidth internal electronic 
amplification schemes and the use of a frame transfer array), an common detector RS-
OCT similar to that demonstrated in aim #3 could be constructed with real-time (> 32 
frames/sec) imaging speeds. The issue of improving the OCT sensitivity would be 
slightly more challenging. In OCT, optimal sensitivity is achieved with an interferometer 
splitting ratio of 50:50. Alternative ratios can be used, but they come at the expense of 
optical heterodyne gain. From here, increasing the power to the sample improves the 
signal to noise. This necessitates detecting an increased DC reference signal, which will 
eventually lead to camera saturation. Thus the camera saturation level is directly related 
to the optimal sensitivity achievable in OCT. The full well capacity of shift register limits 
the maximum signal that could illuminate a CCD array before saturation, and is typically 
a function of the physical size of the array elements. Thus, in order to increase the 
sensitivity of OCT, the pixel heights would have to be increased. In contrast to designing 
custom electronics to pair with a CCD chip to improve imaging speed, obtaining CCD 
chips with custom architectures and pixel sizes is exceedingly difficult. However, if such 
a chip could be obtained, it would be better suited for RS-OCT with a common detector 
arm. 
A third approach to combined RS-OCT would be to attempt to integrate the 
source and detection arms of the system. An alternative approach to dispersing the 
detected OCT light with a spectrometer to detect the spectral interference is to perform 
swept-source OCT (SS-OCT). In SS-OCT, a narrow band laser is rapidly swept across a 
broad spectral band. The interference signal is then detected with a photodiode triggered 
to the scanning of the source to achieve detection of interference as a function of k. Since 
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the Raman spectrum of a sample is typically independent of the excitation wavelength, a 
similar approach could theoretically be used to build up a Raman spectrum. Such an 
approach would require three hardware features; 1.) The combination of laser power and 
detection sensitivity necessary to detect the weakly scattered Raman light. This may be 
possible with high gain avalanche photodiodes (APD) and swept lasers with narrow-band 
peak powers on the order of 20 mW in the near-infrared (i.e. 785 nm), 2.) A narrow-band 
tunable filter in the Raman detection path synched to the laser sweep, and 3.) A laser 
sweep range that generated a Raman spectrum that corresponded to the fingerprint 
region. This approach would surely be a technical challenge, and would require seeking 
out industrial collaboration with those in the tunable filter and swept-source sectors. 
Creating a tunable filter can rapidly scan, and also be locked with the mode stability 
necessary for RS is a fundamental technical challenge that would have to be met. In 
addition, although it is theoretically feasibly, it is unknown whether high gain APD’s 
have the sensitivity necessary to detect Raman scattered light.  
Approaching the challenge of combining RS and OCT from the instrumentation 
perspective is certainly intriguing; however the utility of RS and OCT together is derived 
from their strengths operating at their potential. If the technical arrangement 
compromises either modalities performance, the utility of the combined device is 
diminished. More importantly, the target application’s needs should be considered 
paramount when designing any instrument. In this context, the excitation wavelength 
selection for both modalities is critical. Both Raman and OCT use some form of 
scattering for their signal source. Scattering intensity is known to fall of as a function of 
λ-4. In OCT, this can be advantageous, because imaging depth is not limited by 
instrumentation sensitivity, but by the physical penetration depth of light in tissue. Thus, 
a decrease in scattering can result in an increased penetration depth in the near-infrared (< 
2.0 µm). In RS, on the other hand, decreasing scattering intensity results in the reduction 
of an already weak signal. The potential benefit, however, is that tissue autofluorescence 
falls off significantly in the near-infrared, particular past 1.0 µm. The downside is that 
detection electronics in that band have not yet demonstrated the sensitivity necessary to 
perform high quality RS at that wavelength range.  
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Ultimately, these factors drove the demonstration of common detector RS-OCT 
away from the skin and towards the retina. OCT imaging performance in the skin at 850 
nm is simply insufficient for visualizing the morphological extent of subsurface lesions. 
In addition, hardware limitations prevented image acquisition in a clinically relevant 
timeframe.  
Potential Applications of RS-OCT 
Based upon existing work demonstrating the potential strengths and limitations of 
RS6 and OCT7 in characterizing breast tissue, The RS-OCT approach could be beneficial 
for both evaluating tumor resection margins in vivo for the presence of residual tumor 
cells, as well as for evaluating removed breast tumor samples for clear margins ex vivo. 
Such work could be performed with systems similar that described in aim #2 (for ex vivo 
analysis) and aim #4 (for in vivo analysis).  
In addition to the breast, another possible location for clinical application of RS-
OCT is the gastrointestinal tract. Both OCT8 and RS9 have been demonstrated in these 
tissues with promising results, but similar limitations to those previously mentioned. The 
primary challenge of combined RS-OCT in the GI tract would be probe design. The fiber 
optic cables that carry OCT signal are typically single-mode fiber with core diameters on 
the order of 9 µm or less. Raman spectroscopy, on the other hand, requires multi-mode 
fiber optics with core diameters on the order of 100’s of µm’s, which makes illumination 
and collection with the same fiber optics impossible. A straightforward approach, 
however, would be to use individual RS and OCT fiber probes with a precision designed 
tip that allowed for co-registration of the data sets. The GI tract is extremely 
heterogenous in nature – even more so than the skin – with a number of benign and 
malignant lesions. Similar to the skin, these spectral signatures would have to be recorded 
and classification algorithms would need developed to realize the full potential of a 
combined approach. 
Combined RS-OCT for directing skin cancer therapy 
 The primary motivation for combining RS and OCT was to create a versatile 
clinical instrument that is capable of meeting all the needs for disease detection and the 
direction of treatment. This includes screening, diagnosis, and staging of disease. RS-
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OCT has the ability to perform all of these tasks, and the work shown in aim #4 provides 
an initial clinical demonstration of the instrument’s potential. In order to further 
demonstrate the utility of the technique, a small pilot study should be conducted to 
demonstrate the instruments ability to screen large areas, diagnose disease with high 
accuracy, and identify tumor margins for direction of treatment. This could all be 
accomplished with a small pilot study that enrolled approximately 15 patients with BCC. 
Further studies could demonstrate the devices ability in a wider range of disease classes 
and larger sample size study. 
The limitations of the current clinical system, however, warrant the development 
of a 2nd generation system, which is already underway. The current state-of-the-art OCT 
imaging systems at 1310 nm using spectral domain detection are capable of acquiring 
images at > 50 of frames/sec at resolutions of < 10 µm.  We have acquired a line scan 
camera that is capable of scanning 46x faster than the current system, and a laser source 
with 1/3 broader bandwidth in order to fabricate such an OCT system backbone. The 
ideal approach for RS-OCT the context of skin cancer detection remains to use separate 
system backbones so as not to compromise the performance of either system individually.  
The mechanical arm mounting and support interface could also use improvement. 
Movement in the joints of the arm is due to tension springs, which require a minimum of 
17 lbs of load at the end to keep the arm from rising up to the ceiling. This problem was 
overcome by incorporating an extension rod to the end of the arm to increase the moment 
arm, and also by constructing the probe out of heavy ½” stainless steel instead of ¼” 
aluminum. In addition, the mechanics of the arm at each joint provide only one degree of 
freedom. Although the probe can be positioned in any orientation, it often requires a great 
deal of maneuvering to position the probe joints appropriately. Improving the arm to 
employ ball and socket joints with variable amounts of tightness would likely be a better 
approach.  
The probe interface could also be improved. Aligning the probe with the lesion to 
be measured is difficult, because once the probe is in place, the user cannot visually see 
the lesion, they must rely on the OCT image for guidance. Ideally, the user would be able 
to localize the OCT with a visual image, and the RS with the OCT. A second generation 
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probe should be constructed in order to allow incorporate a miniature CCD to visual 
orientation.  
Beyond these basic improvements, rethinking the physical approach to collecting 
the Raman signal is also warranted. Despite the fact that it is possible to collect RS 
through this configuration, realizing an acquisition time less than 30 seconds would 
enhance the clinical utility of the device. The approach that would minimize the 
collection time the most significantly would be to perform RS with a contact fiber probe. 
The probe could be designed such that the Raman fiber probe would be located out of the 
optical path of the OCT and video imaging. A user controlled mechanical mechanism 
would lower the fibers into place on the lesion. The position of the probe with respect to 
the imaging frame would have to be carefully calibrated, but is possible. Such an 
approach, in combination with the 2nd generation OCT system backbone, would greatly 
improve the speed of the instrument. 
 Furthermore, a bringing collection fibers in contact with the lesion would open 
the possibility collecting from various source-detector offsets and performing Spatially 
Offset RS (SORS)10. The basic concept of SORS is that light detector with larger spatial 
offsets originates from deeper levels of the tissue. The specifics are based on the optical 
properties of the tissue modulating the transport of Raman scattered light.  The potential 
of utilizing a SORS detection scheme is that it allows simultaneous collection of Raman 
scattered light from multiple depths. The disadvantage is that it has nowhere near the 
spatial resolution of confocal RS.  The depths probed by the various spatial offsets are a 
function of tissue optical properties, while the achievable spatial resolution is determined 
by a combination of tissue optical properties and the incremental differences in spatial 
offset that the fibers can be set at. The SORS approach was previously only demonstrated 
in detecting calcified tissues under soft tissues, however recent work demonstrated the 
potential of the technique for differentiating layers of soft tissue as well11. If contact 
fibers were used to collect the Raman scattered light in a future RS-OCT clinical probe, 
segmenting the fibers for SORS analysis could provide useful information on tissue 
composition as a function of depth. 
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Significance 
The tabletop demonstration of combined RS-OCT represented the first work 
reporting the feasibility of a dual-modal device that combined spontaneous RS with OCT. 
Furthermore, it was the first demonstration that such a technique has utility for the 
analysis of malignant breast tissues and in the skin. The skin images and spectra served as 
the first demonstration of the feasibility of RS-OCT analysis in vivo.  Overall the 
manuscript provided the initial identification and demonstration of the potential 
advantages of RS-OCT. 
The common detector RS-OCT manuscript will signify the first demonstration of 
RS and OCT with a common detector. The application to the retina represented the first 
demonstration of RS of the retina through an intact eye. Despite the fact that the power 
delivered to the retina is far in excess of safe exposure standards in the human, the 
differences between the pathological and normal tissues indicate that should an 
alternative method for acquiring Raman signal from the retina allow for safe exposure, 
valuable data could be obtained. The implications of the common detector instrument 
include studies of the morphological and biochemical progression of pathology in animal 
models of retinal disease.  
The clinical instrument for performing RS-OCT of skin cancers was, however, the 
primary end product this dissertation sought out. It is the first demonstration of a dual 
modal optical tool designed to meet the current clinical challenges associated with the 
direction of skin cancer treatment – screening, diagnosis, and staging. This is in contrast 
many previous studies, which were reported by those who simply sought to report the 
utility of a specific optical instrument’s application to a wide variety of clinical problems, 
of which skin cancer was only one. These reports often took shape similar to the 3rd 
manuscript, common detector RS-OCT and it’s application to the retina. They were 
demonstrations of novel instruments that sought an appropriate application. The well 
motivated selection of specific optical techniques for dual- and multi- modal devices is 
becoming a more widely embodied approach to solving specific clinical problems 
amongst those in the biomedical optics community. This shift in mindset certainly would 
not be possible without the wealth of literature describing the application of novel optical 
techniques to a slew of clinical problems. It is important that the biomedical optics 
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community continues to receive contributions from both types of researchers; those with 
hammers running around looking for nails to hit, and those devoted to single problem, 
collecting the best tools to handle it. This dissertation represents a little bit of both 
approaches. While there was significant energy expended on steadily addressing the 
clinical challenges associated with skin cancer, there were also many months spent 
overcoming the obstacles associated with developing a novel instrument and identifying 
an appropriate application.  
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APPENDIX 
 
 
The protocol under which the in vivo combined Raman Spectroscopy – Optical 
Coherence Tomography (RS-OCT) data collected in this dissertation was approved by 
the Vanderbilt University and Veteran’s Affairs Tennessee Valley HealthCare System 
Institutional Review Boards (IRB’s). IRB approval of protocols ensures ethical 
experimental design and patient safety in human experiments. For proof-of-principle and 
pilot studies that are only designed to evaluate the feasibility of novel instruments, it is 
the responsibility of protocol authors to ensure the safe operation of the devices and 
report any adverse affects to the IRB.  Ultimately, the widespread clinical application of 
instruments employing Raman spectroscopy (RS) for skin cancer diagnosis will require 
review and approval by the Food and Drug Administration (FDA) for safety and efficacy. 
With respect to laser safety, the primary guidelines considered by the FDA are taken 
from a report published by the American National Standards Institutes (ANSI) for the 
safe use of lasers1. This report details the maximum permissible exposure (MPE) levels 
for skin, which are defined fairly arbitrarily as 10% of the laser exposure that results in 
the earliest sign of histological laser damage in 50% of samples. For the most part, these 
exposure levels were determined in the late 1960’s and early 1970’s, with narrowly 
defined models and then extrapolated to cover a wide-range of wavelengths and 
illumination geometries. In addition, the levels were determined prior to the development 
of modern methods in cellular and molecular biology that probe more sensitive indicators 
of cellular stress, damage, and viability.  Most importantly, the application of laser-based 
techniques for detection of potentially lethal diseases such as cancer warrants 
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consideration of the potential benefits as well as the risks, similar to the risk/benefit 
assessments typically conducted for novel pharmaceuticals. The lack of context and 
conservative nature of the MPE’s is acknowledged within the FDA, and there exists some 
desire to refine the MPE’s accordingly. As the application of RS for skin cancer 
diagnostics moves forward, however, a large part of the responsibility for demonstrating 
the relative safety of RS for the non-invasive diagnosis of disease will be placed on the 
shoulders of those within the RS community itself.   
The photobiological effects of laser irradiation that can result in tissue damage 
can be separated into three mechanistic categories, 1) photomechanical, 2) photothermal, 
and 3)photochemical. Photomechanical effects are the result of rapid heating and 
expansion of the tissue by pulsed laser sources. The expansion of the tissue produces a 
pressure wave that can disrupt the physical organization of the tissue and result in tissue 
ablation. The pulse durations that typically produce photomechanical effects are typically 
on the order of 10-6 seconds or less, and thus are not a concern for the exposure durations 
used in RS. Photochemical effects result from the activation of chemical reactions (i.e. 
oxidative processes) originating from the absorption of light by specific molecules. 
Absorption by molecules intrinsic to the skin is not known to result in any photochemical 
reactions that result in tissue damage. Photothermal mechanisms are the most likely 
sources of tissue damage induced by RS. On the molecular and cellular level, the 
temperatures at which the denaturation of proteins, hylanization of collagen, de-activation 
of enzymes, cell shrinkage, membrane rupture, and cell death have previously been 
reported2. Measurement of the skin surface temperatures during RS can therefore act as a 
surrogate marker for the effect of the Raman laser beam on the skin. 
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This appendix will describe preliminary experiments designed to evaluate the 
effect that Raman laser exposure levels of combined RS-OCT have on skin by measuring 
the surface temperature of the skin during RS measurement with a thermal camera. The 
results suggest that these effects are minimal, despite the fact that the exposure levels 
used are well in excess of those defined by the ANSI standards. 
 
Materials and Methods 
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Fig.  A.1. Sample arm of the benchtop combined RS-OCT. The Raman illumination is a 785 nm source, 
and the OCT illumination is a 1310 nm source. BP – 785 nm band pass filter, BSO – beam shaping optics, 
DC1 – dichroic mirror 1, DC2 – dichroic mirror 2, GP – galvanometer pair. Thermal imaging is performed 
by the thermal camera. 
 
The experimental setup is shown in figure A.1. Raman illumination and detection 
are identical to the combined RS-OCT system described in chapter 33. A 785 nm external 
cavity diode laser (Sacher GmBH) is focused at the sample to a 75 µm spot with a 
confocal parameter of 770 µm. The power at the sample is 40 mW. During RS-OCT 
measurements, the sample is additionally illuminated by a 1310 nm source with 7 mW of 
power at the sample. The typical exposure time necessary to acquire Raman spectra is 30 
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seconds. Measurements of the skin surface temperature were made with a thermal camera 
(FLIR systems) for a duration beyond the RS acquisition time, beginning just prior to 
illumination. Both beams were blocked prior to the initiation of Raman spectral 
acquisition and temperature measurements. In order to localize the area where the RS-
OCT probe beam irradiated the tissue, a region of interest (ROI) within the image 
corresponding to the position of the Raman illumination beam was identified (fig A.2), 
and the maximum temperature within this area was tracked as a function of time. 
ROI
 
Fig.  A.2. Example Thermal Camera Image and Region of Interest (ROI) Positioning.  
 
 In order to assess the effect of a typical the Raman illumination beam, surface 
temperature traces were recorded over the course of three illumination trials. 
Measurements were made over a duration of 60 seconds with the Raman probe beam at 
40 mW and the OCT probe beam at 7 mW on the back of the hand  A second, slightly 
different measurement was performed near the nail-bed on the back of the finger with the 
Raman probe beam power increased to 50 mW and the temperature measurement 
duration extended to 2 minutes.  
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Results 
The skin surface temperature traces for the first experiment are shown in figure 
A.3. The skin surface temperature was varied at the beginning of the trails between 35˚ 
and 36˚ C, and rapidly increased approximately 3˚ C in the first 20 seconds. The second 
and third trials show the skin surface temperature stabilizing after the initial 20 second 
period. 
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Fig.  A.3. Temperature Traces for PRaman = 40 mW, POCT= 7mW illumination on the back of the hand. 
 
Figure A.4 depicts the temperature trace of the second experiment, a single trial 
conducted at the nail bed over a duration of 2 minutes with the Raman laser power 
increased to 50 mW. Again, there was a rapid initial increase (12˚ C) lasting the initial 45 
seconds, after which the temperature seemed to stabilize at 42˚ C. 
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Raman illuminiation P = 50 mW, nailbed
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Fig.  A.4. Temperature Traces for PRaman = 50 mW, POCT= 7mW illumination on the nail bed. 
 
 
Discussion 
Taken together, figures A.2 and A.3 indicate that the laser exposure levels used in 
RS-OCT result in a moderate increase of 3˚ C to 12˚ C in temperature that stabilizes after 
some time. These steady-state temperatures range from 39.5˚ C to 43˚ C. Previous studies 
evaluating the effects of photothermal effects of laser irradiation on tissue are 
summarized in figure A.52, 4. Over the time course of typical Raman Measurements, a cell 
temperature in excess of 52˚ C has been reported necessary to result in cell death. The 
regime current Raman measurements operate within is shown here to be at most 43˚ C, 
which is much lower. The implication is that current laser exposure parameters for RS do 
not result in irreversible cellular damage or cell death.  
The question of whether or not these laser irradiation parameters affect the skin, 
however is still not answered by these preliminary experiments. Reversible damage to the 
tissue, such as minor burning and localized inflammation, fills the space between no 
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effect and irreversible damage. It is quite likely that the photothermal effects of RS on the 
skin include initiation of the cellular mechanisms involved in the response to thermal 
injury, such as the up regulation of  heat shock protein 704. Measures such as these would 
indicate the severity of reversible cellular stresses, which vary in their severity. 
Evaluating both the short term and long term impact of these stresses in the context of the 
benefits of non-invasive diagnosis of skin cancer on tissue is critical to determining safe 
laser exposure levels.  
 
Fig.  A.5. Photothermal effects of Raman Spectroscopy (RS) in the context of previous reports of 
laser irradiation of cells. Dots represent maximum heat-shock protein 70 expression4.  
  
The ANSI defined MPE’s were not framed in the context of laser induced 
temperature increases or the relative benefit of disease diagnosis, but in the context of a 
fraction of the levels necessary for acute laser damage. In order to calculate the ANSI 
defined MPE for continuous wave laser exposure of the skin, section 8.4 of ANSI 
Standards for Safe Use of Lasers1 was referenced. Calculations of the MPE for the three 
instrument configurations developed in the Vanderbilt University Biomedical Optics lab 
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the actual exposures used are shown in table A.1, along with the degree to which the 
exposure levels used exceed the ANSI limits.  
Table A.1: Laser Exposure for Raman Spectroscopy Devices 
  
Exposure 
(J/cm2) 
MPE 
(J/cm2) 
Fold above 
MPE (x) 
Fiber-Optic Raman 
Probe5 191 2.14 90 
Handheld Confocal 
Raman Microscope6 7.5·10
6
 0.36 21·106 
Benchtop Combined 
RS-OCT3 31,000 0.296 105,000 
 
The fiber-optic Raman probe used in a majority of the work characterizing the cervix and 
cervical dysplasia5, along with the cancerous skin lesions in chapter II, utilizes a 785 nm 
source with a 400 µm illumination fiber. The laser power at the sample was 80 mW and 
is placed directly in contact with the skin for 3 seconds during acquisition. The handheld 
confocal Raman microscope7 used for the in vivo pilot study used an 830 nm source 
focused to a 1.2 µm spot. The laser power at the sample was 40 mW, and the spectral 
acquisition time was 30 seconds. The benchtop combined RS-OCT instrument utilizes a 
785 nm source for RS focused to a 35 µm spot. The corresponding laser exposures for all 
these instruments are well in excess of the ANSI MPE’s. For the combined RS-OCT 
insturment, the exposure levels are more than 100,000 times that of ANSI MPE.  Despite 
what appears to be alarming high levels of laser exposure with all the instruments, none 
of the volunteers whose skin or skin lesions were characterized reported any pain 
associated with RS. Here, we have additionally demonstrated that the exposure levels 
used in RS-OCT do not even result in the necessary temperature levels to induce 
irreversible tissue damage. 
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Conclusion 
 These preliminary experiments serve as a starting point for future work to identify 
the effect of the laser exposure parameters used for RS. The results indicate that the 
exposure levels used in this study result in skin surface temperatures below the threshold 
for irreversible cell damage, despite the fact that they greatly exceed the ANSI limits. In 
order to define reasonable exposure levels that are well placed in the context of patient 
safety/discomfort and the potential benefit non-invasive diagnosis of disease may 
provide, more work is certainly necessary. This work should include the rigorous 
evaluation of a wider range of laser exposure parameters including alternative 
illumination geometries such as those used in the fiber-optic probe or confocal RS. 
Analysis of the impact on tissue should be performed at both the cellular and tissue 
levels.  Direct measures of cellular modulation, such as the up regulation of proteins 
associated with the healing response to thermal injury, should be assessed. Tissue level 
damage should be evaluated by a pathologist trained in discerning the features of laser 
damage. Such work would be well suited to direct the appropriate laser exposure levels 
for RS. 
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